UNITED STATES


SECURITIES AND EXCHANGE COMMISSION


Washington, D.C. 20549

SCHEDULE 14A


Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934

 (Amendment

(Amendment No. )

Filed by the Registrant ☒

Filed by a partyParty other than the Registrant  ☐

Check the appropriate box:


Preliminary Proxy Statement


Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))


Definitive Proxy Statement


Definitive Additional Materials


Soliciting Material under § 240.14a-12§240.14a-12

Charles & Colvard, Ltd.


(Name of Registrant as Specified In Its Charter)



(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check all boxes that apply)the appropriate box):


No fee requiredrequired.


Fee paid previously with preliminary materialsmaterials.


Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-110-11.



170 Southport Drive


Morrisville, North Carolina 27560

 (919) 468-0399

NOTICE OF ANNUAL MEETING OF SHAREHOLDERS

TO BE HELD ON DECEMBER 14, 2023

To the Shareholders of Charles & Colvard, Ltd.:

You are cordially invited to attend the special meeting of shareholders (the “Special Meeting”) of Charles & Colvard, Ltd., which will be held at the principal executive offices of Charles & Colvard, Ltd. located at 170 Southpoint Drive, Morrisville, North Carolina, 27560, on Tuesday, May 7, 2024, at 10:00 a.m., Eastern Time.
Attached to this letter are a Notice of Special Meeting and proxy statement, which describe the business to be conducted at the Special Meeting.
At the Special Meeting, we will ask shareholders:
1.
To approve an amendment to the Restated Articles of Incorporation of Charles & Colvard, Ltd. to effect a reverse stock split of the issued shares of common stock at a ratio within a range from any whole number between one-for-ten to one-for-fifteen, as determined by the Board of Directors in its sole discretion (the “Reverse Stock Split Proposal”); and
2.
To approve one or more adjournments of the Special Meeting to a later date or dates, if necessary, to permit further solicitation of proxies in the event there are not sufficient votes in favor of the Reverse Stock Split Proposal or to constitute a quorum, as described in this proxy statement.
The Board of Directors recommends the approval of each of these proposals. Such other business will be transacted as may properly come before the Special Meeting or any adjournments or postponements thereof.
We hope you will be able to attend the Special Meeting. Whether you plan to attend the Special Meeting or not, it is important that you cast your vote during the Special Meeting or submit your voting instructions by proxy. You may submit your voting instructions over the Internet as well as by telephone or mail. When you have finished reading the proxy statement, you are urged to submit a proxy in accordance with the instructions set forth in this proxy statement. We encourage you to submit a proxy so that your shares will be represented and voted at the Special Meeting, whether or not you attend.
If you have any questions or need assistance in voting your shares of our common stock, please contact our proxy solicitor, Alliance Advisors, via telephone 833-501-4701 or via email CTHR@allianceadvisors.com.
Thank you for your continued support of Charles & Colvard, Ltd. We look forward to the Special Meeting.
Sincerely,
Don O’Connell
President and Chief Executive Officer

PRELIMINARY PROXY STATEMENT -- SUBJECT TO COMPLETION DATED MARCH 28, 2024

170 Southport Drive
Morrisville, North Carolina 27560
NOTICE OF SPECIAL MEETING OF SHAREHOLDERS
TO BE HELD ON MAY 7, 2024
Notice is Hereby Given that the AnnualSpecial Meeting of Shareholders of Charles & Colvard, Ltd. will be held at the principal executive offices of Charles & Colvard, Ltd. located at 170 Southport Drive, Morrisville, North Carolina 27560, on Thursday, December 14, 2023,Tuesday, May 7, 2024, at 10:00 a.m., Eastern Time, for the following purposes:

1.
To elect five nominees described inapprove an amendment to the proxy statementRestated Articles of Incorporation of Charles & Colvard, Ltd. (the “Proposed Amendment”) to effect a reverse stock split of the issued shares of common stock at a ratio within a range from any whole number between one-for-ten to one-for-fifteen, as determined by the Board of Directors;
Directors in its sole discretion (the “Reverse Stock Split Proposal”); and
2.
To ratify the appointment of BDO USA, P.C. as our independent registered public accounting firm for the fiscal year ending June 30, 2024;
3.To vote, on an advisory (nonbinding) basis,approve one or more adjournments of the Special Meeting of Shareholders to approve executive compensation; and
4.
To transact such other businessa later date or dates, if necessary, to permit further solicitation of proxies in the event there are not sufficient votes in favor of the Reverse Stock Split Proposal or to constitute a quorum, as may properly come before the meeting or any adjournment thereof.
described in this proxy statement.


The Board of Directors has fixed the close of business on October 17, 2023March 26, 2024, as the record date for the determination of shareholders entitled to vote at the meeting.Special Meeting of Shareholders. Accordingly, only shareholders who are holders of record at the close of business on that date are entitled to notice of and to vote at the meeting.

By order of the Board of Directors,
 
Neal I. Goldman
Chairman of the Board of Directors

October 27, 2023

We are providing access to our proxy materials over the Internet pursuant to the Securities and Exchange Commission’s “notice and access” rules. On or about October 27, 2023, we expect to mail to our shareholders a Notice of Internet Availability of Proxy Materials (the “Notice”) that will indicate how to access our 2023 Proxy Statement, Fiscal 2023 Annual Report on Form 10-K and Shareholder Letter on the Internet and will include instructions on how you can receive a paper copy of the annual meeting materials, including the notice of annual meeting, proxy statement, and proxy card.

April [•], 2024
Whether or not you expect to attend the special meeting in person, please submit voting instructions for your shares promptly using the directions on your Notice, or, if you elected to receive printed proxy materials by mail, your proxy card, to vote by one of the following methods: 1) over the Internet at www.voteproxy.comwww.voteproxy.com; 2) over the telephone by calling 1-800-776-9437 in the United States or 2) if you elected to receive printed proxy materials by mail,1-201-299-4446 from foreign countries; or 3) by marking, dating, and signing your proxy card and returning it in the accompanying postage-paid envelope. Even if you have voted by proxy, you may still vote in person if you attend the meeting. Please note, however, that if your shares are held of record by a broker, bank, or other nominee and you wish to vote at the meeting, you must obtain a proxy issued in your name from that record holder.



170 Southport Drive


Morrisville, North Carolina 27560


(919) 468-0399

PROXY STATEMENT

FOR THE SPECIAL MEETING OF SHAREHOLDERS

TO BE HELD ON MAY 7, 2024
This proxy statement, is furnished toalong with the shareholdersaccompanying Notice of Special Meeting of Shareholders, contains information about the Special Meeting of Shareholders (the “Special Meeting”) of Charles & Colvard, Ltd. (the “Company”) in connection withincluding any adjournments or postponements of the Special Meeting. We are holding the Special Meeting at the principal executive offices of Charles & Colvard, Ltd. located at 170 Southport Drive, Morrisville, North Carolina 27560, on Tuesday, May 7, 2024, at 10:00 a.m., Eastern Time.
In this proxy statement, we refer to Charles & Colvard as “the Company,” “we” and “us.”
This proxy statement relates to the solicitation of proxies by our Board of Directors (the “Board”) for use at the Special Meeting.
This Notice of Special Meeting and proxy statement are first being distributed or made available, as the case may be, to our Company’s 2023 Annualshareholders on or about April [•], 2024.
IMPORTANT INFORMATION ABOUT THE SPECIAL MEETING AND VOTING
Important Notice Regarding the Availability of Proxy Materials for the Special Meeting to Be Held on May 7, 2024.
The Company is providing you with access to proxy materials because our Board is soliciting your proxy to vote at the Special Meeting to be held at the principal executive offices of Shareholdersthe Company located at 170 Southport Drive, Morrisville, North Carolina 27560, on Tuesday, May 7, 2024, at 10:00 a.m., Eastern Time and any adjournments or postponements of the Special Meeting. You will receive paper copies of all of our proxy materials by mail and can also access our proxy materials online at www.voteproxy.com or in the Investor Relations section of our website. You are invited to attend the Special Meeting to vote on the proposals described in this proxy statement. However, you do not need to attend the Special Meeting to vote your shares.
Who Can Vote at the Special Meeting?
Only shareholders who owned our common stock at the close of business on March 26, 2024 (the “Annual Meeting”“Record Date”) are entitled to vote at the Special Meeting. On the Record Date, there were 30,344,955 shares of our common stock issued and all adjournments thereof. outstanding and entitled to vote. Our common stock is our only class of voting stock outstanding.
How Many Votes Do I Have?
Each share of our common stock that you owned as of the Record Date entitles you to one vote.
What am I voting on?
There are two (2) proposals scheduled for a vote at the Special Meeting:
Proposal 1:
To approve an amendment to the Restated Articles of Incorporation of the Company to effect a reverse stock split of the issued shares of common stock at a ratio within a range from any whole number between one-for-ten to one-for-fifteen, as determined by the Board in its sole discretion (the “Reverse Stock Split Proposal”); and
Proposal 2:
To approve one or more adjournments of the Special Meeting to a later date or dates, if necessary, to permit further solicitation of proxies in the event there are not sufficient votes in favor of the Reverse Stock Split Proposal or to constitute a quorum, as described in this proxy statement (the “Adjournment Proposal”).
1

How Does the Board Recommend that I Vote on the Proposals?
The AnnualBoard recommends that you vote (i) “FOR” the Reverse Stock Split Proposal; and (ii) “FOR” the Adjournment Proposal.
How Can I Attend the Special Meeting?
The Special Meeting will be held at the principal executive offices of Charles & Colvard, Ltd. located at 170 Southport Drive, Morrisville, North Carolina 27560, on Thursday, December 14, 2023Tuesday, May 7, 2024, at 10:00 a.m., Eastern Time,Time. You do not need to conductattend the following businessSpecial Meeting in order to vote.
How Do I Vote?
Whether you plan to attend the Special Meeting or not, we urge you to submit your voting instructions by proxy. All shares represented by valid proxies that we receive through this solicitation, and such other businessthat are not revoked, will be voted in accordance with your instructions on the proxy card or as may be properly brought before the meeting: (1) to elect five nominees described in this proxy statement to the Board of Directors; (2) to ratify the appointment of BDO USA, P.C. (“BDO”) as our independent registered public accounting firm for the fiscal year ending June 30, 2024; and (3) to vote, on an advisory (nonbinding) basis, to approve executive compensation.

The Board of Directors recommends that you vote (1) FOR the election of the director nominees listed in this proxy statement, (2) FOR ratification of the appointment of BDO as our independent registered public accounting firm for the fiscal year ending June 30, 2024, and (3) FOR the approval of executive compensation.

Notice of Internet Availability of Proxy Materials

Pursuant to the “notice and access” rules of the Securities and Exchange Commission (the “SEC”), we are furnishing proxy materials to our shareholdersinstructed via the Internet. Beginning onInternet or about October 27, 2023, we intendtelephone. You may specify whether your shares should be voted for, against or abstain with respect to mail(i) the Reverse Stock Split Proposal; and (ii) the Adjournment Proposal.

If you properly submit a proxy without giving specific voting instructions, your shares will be voted in accordance with the Board’s recommendations as noted below. Voting by proxy will not affect your right to attend the Special Meeting. If your shares are registered directly in your name through our shareholders a Notice of Internet Availability of Proxy Materials (the “Notice”) containing instructions on how to access our proxy materials onstock transfer agent, Equiniti Trust Company, LLC, or you have stock certificates registered in your name, you may vote:
By the Internet including our proxy statement, our Fiscal 2023 Annual Report on Form 10-K and Shareholder Letter. The Notice also instructs you on how you can vote using the Internet.

Internet distribution of our proxy materials is designed to expedite receiptor by shareholders, lower the cost of the Annual Meeting, and conserve natural resources. If, however, you would prefer to receive printed proxy materials, please followtelephone. Follow the instructions included in the Notice.

Voting Securities

Our common stock, no par value per share, is our Company’s only outstandingproxy card to submit your voting security. The Board of Directors has fixedinstructions over the close of businessInternet or by telephone.

By mail. You can have your shares voted by mail by completing, signing, dating, and returning the proxy card as instructed on October 17, 2023the card. If you sign the proxy card but do not specify how you want your shares voted, they will be voted in accordance with the Board’s recommendations as the record date for the determination of shareholders entitled to votenoted below.
In person at the Annualmeeting. If you attend the Special Meeting, you may deliver a completed proxy card in person or you may vote by completing a ballot, which will be available at the Special Meeting. Accordingly, each
Telephone and Internet voting facilities for shareholders of record will be available 24 hours a day and will close at 11:59 p.m. Eastern Time on May 6, 2024.
If your shares are held in “street name” (held in the name of a bank, broker, or other holder of record), you will receive instructions from the holder of record. You must follow the instructions of the holder of record in order for your shares to be voted. Telephone and Internet voting also will be offered to shareholders owning shares through certain banks and brokers. If your shares are not registered in your own name and you plan to vote your shares in person at the Special Meeting, you should contact your broker or agent to obtain a legal proxy or broker’s proxy card and bring it to the Special Meeting in order to vote.
May I Change or Revoke My Proxy?
If you give us your proxy, you may change or revoke it at any time before the Special Meeting. You may change or revoke your proxy in any one of the following ways:
by signing a new proxy card with a date later than your previously delivered proxy and submitting it as instructed above;
by submitting your proxy by the Internet or by telephone as instructed above;
by notifying the Corporate Secretary in writing at the Company’s principal executive offices before the Special Meeting that you have revoked your proxy; or
by attending the Special Meeting in person and voting in person. Attending the Special Meeting in person will not in and of itself revoke a previously submitted proxy. You must specifically request at the Special Meeting that it be revoked.
Your most current vote, whether by telephone, the Internet, proxy card or in person at the Special Meeting, is the one that will be counted.
2

What if I Receive More Than One Proxy Card?
You may receive more than one proxy card if you hold shares of our common stock in more than one account, which may be in registered form or held in street name. Please vote in the manner described above under “How Do I Vote?” for each account to ensure that all of your shares are voted.
Will My Shares be Voted if I Do Not Submit a Proxy or Vote in Person?
If your shares are registered in your name or if you have stock certificates, they will not be counted if you do not vote as ofdescribed above under “How Do I Vote?” If your shares are held in “street name” and you do not provide voting instructions to the record date is entitled to onebank, broker or other nominee that holds your shares as described above under “How Do I Vote?”, the bank, broker or other nominee that holds your shares may generally vote your shares without instruction on routine matters but not on non-routine matters. A broker “non-vote” occurs when your broker submits a proxy for your shares but does not indicate a vote for each share of common stock held. Shareholders doa particular “non-routine” proposal because your broker does not have cumulativeauthority to vote on that proposal and has not received specific voting rights. As of October 17, 2023, there were 30,523,705instructions from you. Brokers and other nominees who are New York Stock Exchange members are expected to have discretionary voting power for both the Reverse Stock Split Proposal and the Adjournment Proposal. To ensure your shares of common stock outstanding.

will be voted at the Special Meeting in the manner that you desire, we encourage you to provide voting instructions to your bank, broker or other nominee.

What Constitutes a Quorum and Vote Required

for the Special Meeting?

The holders of a majority of the shares of common stock entitled to vote at the AnnualSpecial Meeting, present in person or represented by proxy, constitute a quorum for purposes of voting on a particular matter and conducting business at the AnnualSpecial Meeting. Votes “for” and “against,” abstentions, shares thatof shareholders of record who are withheld as to voting with respect to one or more of the director nominees, and shares held by a broker, as nominee, that are votedpresent at the discretion of theSpecial Meeting in person or by proxy, abstentions, and broker on any matter will be considered to be presentnon-votes are counted for purposes of determining whether a quorum exists. If a quorum is present at the beginningAs of the Annual Meeting,Record Date, the shareholders may continue to transact business until adjournment, notwithstanding the withdrawal of enough shareholders to leave less than a quorum.

Brokers who are memberspresence in person or by proxy of the New York Stock Exchange (the “NYSE”) and who holdholders of 15,172,478 shares of our common stock in street name for beneficial owners have authority to vote on certain items when they have not received instructions from beneficial owners. Under the rules of the NYSE, the proposal to ratify the appointment of the independent registered public accounting firm is considered a “discretionary” item. This means that brokers may vote in their discretion on this matter on behalf of beneficial owners who have not furnished voting instructions. In contrast, certain items are considered “non-discretionary,” and a “broker non-vote” occurs when brokers do not receive voting instructions from beneficial owners with respect to such items. The proposal to elect directors and the proposal to approve executive compensation are “non-discretionary” items. Therefore, brokers that have not received voting instructions from beneficial owners with respect to these proposals may not vote in their discretion on behalf of such beneficial owners.


Under North Carolina law and our Bylaws, and assuming the existence of a quorum, directors are elected by a plurality of the votes cast by the shares of common stock present in person or by proxy and entitled to vote inat the election of directors. Shares thatSpecial Meeting would be required to achieve a quorum.

What Vote is Required to Approve the Proposals?
Proposal 1:
The affirmative vote of the holders of a majority of the issued and outstanding shares of common stock is required to approve the amendment to the Restated Articles of Incorporation of the Company to effect a reverse stock split of the issued shares of common stock at a ratio within a range from any whole number between one-for-ten to one-for-fifteen, as determined by the Board in its sole discretion.
Proposal 2:
The Adjournment Proposal will be approved if the affirmative votes cast “FOR” the proposal exceed the negative votes cast “AGAINST” the proposal.
How are withheld as to voting with respect to a director nominee and shares held of record by a broker, as nominee, that are not votedVotes Counted?
Votes will not be counted for purposesby the inspector of electing directors.

Under our Bylaws, the proposal to ratify the appointment of BDO as the independent registered public accounting firmelections appointed for the fiscal year ending June 30, 2024meeting, who will be approvedseparately count votes “FOR” and “AGAINST”, abstentions and, if the number of shares voted in favor of the proposal exceeds the number of shares voted against the proposal.applicable, broker non-votes. Abstentions and broker non-votes will noteach be counted in the number of shares represented for purposes of determining whether a quorum is present and represents a share entitled to vote at the proposal has received sufficient votes for approval.

With respect toSpecial Meeting but is not counted as a vote cast. As a result, an abstention or broker non-vote will (1) count as a vote “AGAINST” the advisory (nonbinding) vote to approve executive compensation, such proposalReverse Stock Split Proposal; and (2) will be approved if the votes cast for approval exceed the votes cast against approval for such proposal. Because the vote to approve executive compensation is advisory, your vote will not be binding upon the Board of Directors, your vote will not overrule any decision by the Board of Directors, and your vote will not create or imply any additional fiduciary dutieshave no effect on the Board of Directors or any of its members. However, the Compensation Committee of the Board of Directors will take into account the outcome of the votes when considering future executive compensation arrangements. Abstentions and broker non-votes will not be counted for purposes of determining whether the proposal has received sufficient votes for approval.

Adjournment Proposal.

Do Shareholders have Appraisal Rights?
Under North Carolina law, our shareholdersthere are not entitledno rights to appraisal rights with respect to the matters to be acted upon at the Special Meeting.
What Interests do the Company’s Executive Officers and Directors Have in the Approval of the Reverse Stock Split Proposal?
Certain of our executive officers and directors have an interest in the Reverse Stock Split Proposal as a result of their ownership of shares of common stock. However, we do not believe that our executive officers or directors have interests in the Reverse Stock Split Proposal that are different than or greater than those of any of our other shareholders.
3

Where Can I Find the Voting Results of the Special Meeting?
The preliminary voting results will be announced at the Special Meeting, and we will publish preliminary, or final results, if available, in a Current Report on Form 8-K within four business days of the Special Meeting. If final results are unavailable at the time we file the Form 8-K, then we will file an amended report on Form 8-K to disclose the final voting results within four business days after the final voting results are known.
What Are the Costs of Soliciting these Proxies?
Your proxy is being solicited by our Board on the proposals in this proxy statement.

Voting Procedures

You may vote shares by proxy or in person using one of the following methods:

Voting by Internet. You can vote over the Internet by following the directions on your Notice to access the website address at www.voteproxy.com. The deadline for voting over the Internet is Wednesday, December 13, 2023 at 11:59 p.m. Eastern Time.

Voting by Mail. If you requested printed proxy materials, you can vote by completing and returning your signed proxy card. To vote using your proxy card, please mark, date, and sign the card and return it by mail in the accompanying postage-paid envelope. You should mail your signed proxy card sufficiently in advance for it to be received by Wednesday, December 13, 2023.

Voting in Person. You can vote in person at the meeting if you are the record owner of the shares to be voted. You can also vote in person at the meeting if you present a properly signed proxy that authorizes you to vote shares on behalf of the record owner. If a broker, bank, or other nominee holds your shares, to vote in person at the meeting you must present a letter or other proxy appointment, signed on behalf of the broker or nominee, granting you authority to vote the shares.

You can revoke your proxy and change your vote by (1) attending the meeting and voting in person; (2) delivering written notice of revocation of your proxybeing presented to the Corporate Secretaryshareholders at any time before voting is closed; (3) timely submitting new voting instructions over the Internet as described above; or (4) if you requested printed proxy materials, timely submitting a signed proxy card bearing a later date.

If you timely submit your proxy over the Internet or by proxy card as described aboveSpecial Meeting and have not revoked it, your shares will be voted or withheld from voting in accordance with the voting instructions you gave. If you timely submit your proxy as described above without giving voting instructions, your shares will be voted “for” the election of the persons nominated to serve as the directors of our Company and named in this proxy statement, “for” the proposal to ratify the appointment of BDO as our independent registered public accounting firm for the fiscal year ending June 30, 2024, “for” the approval of executive compensation, and in such manner as the proxies appointed for the Annual Meeting in their discretion determine upon such other business as may properly come before the Annual Meeting or any adjournment thereof.

2

Expenses of Solicitation

Wewe will bear the entire cost of the solicitation of proxies from our shareholders. FollowingThe Company has agreed to pay Alliance Advisors LLC (“Alliance Advisors”) a fee of $10,000 to assist us in the mailingsolicitation of thisvotes described above. The Company will also reimburse Alliance Advisors for reasonable costs estimated not to exceed $5,000 and will indemnify Alliance Advisors against certain liabilities arising out of their engagement. You may contact Alliance Advisors at:

Alliance Advisors
200 Broadacres Drive, 3rd Floor
Bloomfield, New Jersey 07003
833-501-4701
CTHR@allianceadvisors.com
In addition to these mailed proxy statement and the accompanying proxy card,materials, our directors and executive officers and employees may also solicit proxies on behalf of our Company in person, by telephone or by other electronic means. Wemeans of communication. These parties will not be paid any additional compensation for soliciting proxies. The Company may also reimburse persons holding sharesbrokerage firms, banks and other agents for others in their names or in thosethe cost of their nominees for their reasonable expenses in sendingforwarding proxy materials to their principals and obtaining their proxies.

Attending the Annual Meeting

Our Company’s shareholders who held shares of our common stock as of the close of business on October 17, 2023 may attend the Annual Meeting. For any questions regarding attending the Annual Meeting, including directions to the Annual Meeting, or our policies in place at the time of the meeting, please contact the Corporate Secretary at (919) 468-0399.

beneficial owners.

Householding

Some banks, brokers and similar institutions may participate in the practice of “householding” Notices or otherof proxy materials. This means that only one copy of our Notice or other proxy materials may have been sent to multiple stockholdersshareholders in your household. We will promptly deliver a separate copy of the Notice or other proxy materials to you if you write to us at the following address or call us at the following phone number:

Charles & Colvard, Ltd.


Attention: Corporate Secretary


170 Southport Drive


Morrisville, North Carolina 27560


Phone: Call (919) 468-0399 and ask to speak to the Corporate Secretary.

Secretary

To receive separate copies of the Notice or other proxy materials in the future, or if you are receiving multiple copies and would like to receive only one copy for your household, you should contact your bank, broker or similar institution or you may contact us at the above address or telephone number.

34

PROPOSAL 1

ELECTION

AMENDMENT TO THE RESTATED ARTICLES OF DIRECTORS

Our businessINCORPORATION TO EFFECT A REVERSE

SPLIT OF THE COMPANY’S COMMON STOCK
The Reverse Stock Split Proposal
The Board is seeking shareholder approval of an amendment to the Company’s Restated Articles of Incorporation (the “Proposed Amendment”) to effect a reverse stock split of the issued shares of common stock at a ratio within a range from any whole number between one-for-ten to one-for-fifteen, as determined by the Board in its sole discretion (the “Reverse Stock Split”). The Board has unanimously adopted and affairs are manageddeclared advisable the Proposed Amendment and recommends that our shareholders approve the Proposed Amendment. The foregoing description of the Proposed Amendment is a summary and is subject to the full text of the Amendment, which is attached hereto as Appendix A.
If shareholders approve the Reverse Stock Split Proposal, the Board will, in its discretion, determine the Reverse Stock Split ratio within the range described herein, cause the Proposed Amendment to be filed with the North Carolina Secretary of State, and effect the Reverse Stock Split. We will not reduce the number of authorized shares of common stock in connection with the Reverse Stock Split. No further action on the part of shareholders will be required to implement the Reverse Stock Split.
The Proposed Amendment will effect a Reverse Stock Split of the issued shares of the Company’s common stock at a Reverse Stock Split ratio within a range from any whole number between one-for-ten to one-for-fifteen, as determined by the Board in its sole discretion and publicly announced by the Board prior to the effectiveness of the Reverse Stock Split. As of the Record Date, 30,344,955 shares of our common stock were issued and outstanding. Based on such number of shares of our common stock issued and outstanding, immediately following the effectiveness of the Reverse Stock Split (and without giving effect to the rounding up of fractional shares to the nearest whole share), we will have, depending on the Reverse Stock Split ratio selected by the Board, the number of issued and outstanding shares of common stock as illustrated in the table under the directioncaption “–Effects of the Reverse Stock Split–Effect on Shares.” Except for any changes as a result of the treatment of fractional shares as discussed below, all holders of the Company’s common stock will be affected proportionately by the Reverse Stock Split.
No fractional shares of common stock will be issued as a result of the Reverse Stock Split. Instead, any fractional shares that would otherwise be issuable as a result of the Reverse Stock Split will be rounded up to the nearest whole share. No cash payments will be made in respect of any fractional shares. Our common stock will continue to have no par value per share (see “–Effects of the Reverse Stock Split–Reduction in Stated Capital”).
In the event that our shareholders fail to approve the Reverse Stock Split Proposal, the Company could be prevented from regaining compliance with the minimum $1.00 bid price requirement for continued listing set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”), unless the market price of our common stock increases above the Minimum Bid Price Requirement in accordance with Nasdaq Listing Rules. If Nasdaq delists our common stock, then our common stock would likely become traded on the over-the-counter market maintained by OTC Markets Group Inc., which does not have the substantial corporate governance or quantitative listing requirements for continued trading that Nasdaq has. In that event, interest in our common stock may decline, and certain institutions may not have the ability to trade in our common stock, all of which could have a material adverse effect on the liquidity or trading volume of our common stock. If our common stock becomes significantly less liquid due to delisting from Nasdaq, our shareholders may not have the ability to liquidate their investments in our common stock as and when desired, and we believe our access to capital would become significantly diminished as a result. Also, due to certain state securities (blue sky) law requirements which apply to securities that are not listed on an exchange, our ability to consummate future public offerings would be materially limited, and could require that the Company undertake private placements of its debt or equity securities on terms that are significantly less favorable than if such securities were offered in a public offering.
Reason for the Reverse Stock Split
The Company’s common stock is listed on the Nasdaq Capital Market. On June 12, 2023, we received notification from Nasdaq’s Listing Qualifications Department indicating that the Company was not in compliance with the Minimum Bid Price Requirement. In accordance with Nasdaq Listing Rules, the Company was afforded 180 calendar days (until December 11, 2023) to regain compliance with the Minimum Bid Price Requirement. On
5

December 12, 2023, the Company received a notification from Nasdaq’s Listing Qualifications Department indicating that, while the Company had not regained compliance with the Minimum Bid Price Requirement, it was eligible for an additional 180-day grace period, or until June 10, 2024, to regain compliance with the Minimum Bid Price Requirement. Nasdaq’s determination to grant an additional 180-day grace period was based on the Company meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market, with the exception of the Minimum Bid Price Requirement, and on the Company’s written notice to Nasdaq on December 11, 2023 of its intention to cure the deficiency during the additional 180 calendar day compliance period, which compliance could be achieved by effecting a reverse stock split, if necessary. If the Company does not regain compliance by June 10, 2024, the Company expects that Nasdaq will provide written notification that the Company’s common stock will be delisted. At that time, the Company could appeal Nasdaq’s delisting determination to a Nasdaq hearing panel.
The Reverse Stock Split will reduce the number of the Company’s shares of common stock outstanding and increase the Company’s share price. The Company expects that an increase in the Company’s share price due to the Reverse Stock Split will enable the Company to regain compliance with the Minimum Bid Price Requirement and continue to trade on the Nasdaq Capital Market, though there can be no assurance that such action will achieve such purpose.
Board Discretion to Effect the Reverse Stock Split
If the Reverse Stock Split Proposal is approved by our shareholders, the Board will have the sole discretion to implement the Reverse Stock Split or to not effect the Reverse Stock Split at all. The Board currently intends to effect the Reverse Stock Split. If the trading price of Directors,our common stock increases without effecting the Reverse Stock Split, the Reverse Stock Split may not be necessary.
Criteria to be Used for Determining the Reverse Stock Split Ratio
In determining which Reverse Stock Split ratio to implement following the receipt of the requisite shareholder approval, the Board will consider, among other matters, various factors, including, without limitation:
the historical and then-prevailing trading price and trading volume of our common stock;
the expected impact of the Reverse Stock Split on the trading price of our common stock and the trading market of our common stock, in each case, in the short- and long-term;
the Company’s ability to continue its listing on the Nasdaq Capital Market;
the per share price of our common stock immediately prior to the Reverse Stock Split;
the expected stability of the per share price of our common stock following the Reverse Stock Split;
the likelihood that the Reverse Stock Split will result in increased marketability and liquidity of our common stock;
our market capitalization before, and anticipated market capitalization after, the Reverse Stock Split; and
the prevailing general market and economic conditions.
Risks Associated with the Reverse Stock Split
We expect the Reverse Stock Split to increase the market price of our common stock. However, the effect of the Reverse Stock Split on the market price of our common stock cannot be predicted with any certainty, and the history of reverse stock splits for other companies is varied, particularly since some investors may view a reverse stock split negatively. It is possible that the per-share price of our common stock after the Reverse Stock Split will not increase in the same proportion as the reduction in the number of our outstanding shares of common stock following the Reverse Stock Split. Even if we implement the Reverse Stock Split, the market price of our common stock may decrease due to factors unrelated to the Reverse Stock Split, including our future performance and general market conditions in our industry.
Further, following the Reverse Stock Split, because we are not reducing the number of authorized shares of common stock in connection with the Reverse Stock Split, we will have additional shares available to issue upon conversion or exercise of securities of the Company that are convertible into or exercisable for common stock. In
6

addition, we may require significant proceeds from sales of our debt or equity securities to fund our operations in the near term, which will cause further dilution to shareholders. The issuance of a substantial amount of shares of common stock or securities convertible into or exercisable for our common stock in the future could put downward pressure on the price of our common stock.
Following the Reverse Stock Split, if implemented, there can be no assurance that the market price of our common stock will rise in proportion to the reduction in the number of outstanding shares resulting from the Reverse Stock Split or that the market price of the post-split common stock can be maintained above $1.00. There also can be no assurance that our common stock will not be delisted from Nasdaq for other reasons.
The Board believes that the Reverse Stock Split may result in an increase in the market price of our common stock, which could lead to increased interest in our common stock and possibly promote greater liquidity for our shareholders. However, the Reverse Stock Split will also reduce the total number of outstanding shares of common stock, which may lead to reduced trading and a smaller number of market makers for our common stock, particularly if the price per share of our common stock does not increase as a result of the Reverse Stock Split.
If the Reverse Stock Split is implemented, it will increase the number of shareholders who own “odd lots” of fewer than 100 shares of common stock. A purchase or sale of fewer than 100 shares of common stock (an “odd lot” transaction) may result in incrementally higher trading costs through certain brokers, particularly “full service” brokers. Therefore, those shareholders who own fewer than 100 shares of common stock following the Reverse Stock Split may be required to pay higher transaction costs if they sell their common stock.
The Reverse Stock Split may be viewed negatively by the market and, consequently, could lead to a decrease in our overall market capitalization. If the per share market price of our common stock does not increase in proportion to the Reverse Stock Split ratio, or following such increase does not maintain or exceed such price, then the value of our Company, as measured by our market capitalization, will be reduced. Additionally, any reduction in our market capitalization may be magnified as a result of the smaller number of total shares of common stock outstanding following the Reverse Stock Split.
Effective Date
If the Reverse Stock Split Proposal is approved by shareholders and implemented by the Company, we will file the Proposed Amendment with the North Carolina Secretary of State, which will indicate the date and time that the Reverse Stock Split will become effective (the “Effective Date”). The exact timing of the Effective Date and the filing of the Amendment will be determined by the Board based upon its evaluation of when such action will be most advantageous to the Company and our shareholders. The Board reserves the right, notwithstanding shareholder approval and without further action by our shareholders, to elect not to proceed with the Reverse Stock Split if, at any time prior to filing the Proposed Amendment to effect the Reverse Stock Split, the Board, in its sole discretion, determines that they are no longer in the best interests of the Company and our shareholders.
Fractional Shares
If the Reverse Stock Split will result in the issuance of fractional shares, the Company will not issue fractional shares. Instead, any fractional shares that would otherwise be issuable as a result of the Reverse Stock Split will be rounded up to the nearest whole share. No cash payments will be made in respect of any fractional shares.
Effects of the Reverse Stock Split
After the Effective Date of the Reverse Stock Split, each shareholder will own a reduced number of shares of common stock. However, the Reverse Stock Split will affect all of our shareholders uniformly and will not affect any shareholder’s percentage ownership interest in the Company (except to the extent of the rounding up of fractional shares, in which case the Company does not expect any such increase to be material). Voting rights and other rights and preferences of the holders of our common stock will not be affected by the Reverse Stock Split. The number of shareholders of record will not be affected by the Reverse Stock Split.
The principal effects of the Reverse Stock Split will be that:
the number of issued shares of common stock, including shares of common stock held in treasury, will be reduced proportionately based on the final Reverse Stock Split ratio, as determined by the Board in its sole discretion;
7

based upon the Reverse Stock Split ratio selected by the Board, proportionate adjustments will be made to the per-share exercise price, grant price, purchase price and/or the number of shares subject to all then outstanding stock options, restricted stock units and other awards (collectively, the “Equity Awards”) issued under our 2008 Stock Incentive Plan and 2018 Equity Incentive Plan (each, a “Plan” and, collectively, the “Plans”), which will result in a proportional decrease in the number of shares of our common stock reserved for issuance upon exercise of such Equity Awards;
the number of shares then reserved for issuance under the Plans will be reduced proportionately based upon the Reverse Stock Split ratio selected by the Board; and
all share and per share amounts in our financial statements and the notes thereto will be retroactively adjusted for all periods to give effect to the Reverse Stock Split.
Although the number of outstanding shares of our common stock would decrease following the Reverse Stock Split, the Board does not intend for a Reverse Stock Split to be the first step in a “going private transaction” within the meaning of Rule 13a-3 of the Exchange Act.
The following table contains approximate information, based on share information as of March 26, 2024, the Record Date, relating to our outstanding common stock based on the proposed Reverse Stock Split assuming that the Reverse Stock Split Proposal is approved and the Reverse Stock Split is implemented without giving effect to any adjustments for fractional shares of common stock, as of the Record Date.
 
Before Reverse
Stock Split
Reverse Stock Split
Ratio of one-for-ten
Reverse Stock Split
Ratio of one-for-fifteen
Number of Shares of Common Stock Authorized
50,000,000
50,000,000
50,000,000
Number of Shares of Common Stock Issued and Outstanding
30,344,955
3,034,496
2,022,997
Number of Shares of Common Stock Held in Treasury
388,403
38,841
25,894
Number of Shares of Common Stock Reserved for Issuance Pursuant to Outstanding Equity Awards
2,868,942
286,895
191,263
After the Effective Date of the Reverse Stock Split, our common stock would have a new committee on uniform securities identification procedures (CUSIP) number, a number used to identify our common stock. Our common stock would continue to be reported on the Nasdaq Capital Market under the symbol “CTHR.”
The common stock is currently registered under Section 12(b) of the Exchange Act, and we are subject to the periodic reporting and other requirements of the Exchange Act. The proposed Reverse Stock Split will not affect the registration of the common stock under the Exchange Act.
Stated Capital
Pursuant to the Reverse Stock Split, the Company’s common stock will remain having no par value per share. Our shareholders’ equity, in the aggregate, will remain unchanged. The per share common stock net income or loss and net book value will be increased because there will be fewer shares of common stock outstanding. The shares of common stock held in treasury will also be reduced proportionately based on the exchange ratio of the Reverse Stock Split. Retroactive restatement will be given to all share numbers in the financial statements and accordingly all amounts including per share amounts will be shown on a post-split basis. We do not anticipate that any other accounting consequences would arise as a result of the reverse stock split.
Shares Held in Book-Entry and Through a Broker, Bank or Other Nominee
The combination of, and reduction in, the number of our outstanding shares of common stock as a result of the Reverse Stock Split will occur automatically at the Effective Date without any additional action on the part of our shareholders.
Upon the Reverse Stock Split, we intend to treat shareholders holding shares of our common stock in “street name” (that is, through a broker, bank, or other nominee) in the same manner as registered shareholders whose shares of our common stock are registered in their names. Brokers, banks, or other nominees will be instructed to effect the Reverse Stock Split for their beneficial holders holding shares of our common stock in “street name”; however, these brokers, banks or other nominees may apply their own specific procedures for processing the Reverse Stock Split.
8

If you hold your shares of our common stock with a broker, bank, or other nominee, and you have any questions in this regard, we encourage you to contact your broker, bank, or nominee.
If you hold registered shares of our common stock in a book-entry form, you do not need to take any action to receive your post-Reverse Stock Split shares of our common stock in registered book-entry form. If you are entitled to post-Reverse Stock Split shares of our common stock, a transaction statement will automatically be sent to your address of record as soon as practicable after the Effective Date indicating the number of shares of our common stock you hold.
If you hold any of your shares of our common stock in certificate form, you will receive a transmittal letter from our exchange agent as soon as practicable after the Effective Date. The transmittal letter will be accompanied by instructions specifying how you can exchange your certificate representing the pre-Reverse Stock Split shares of our common stock for either: (1) a certificate representing the post-Reverse Stock Split shares of our common stock or (2) post-Reverse Stock Split shares of our common stock in a book-entry form, evidenced by a transaction statement that will be sent to your address of record as soon as practicable after the Effective Date indicating the number of shares of our common stock you hold. Beginning on the Effective Date of the Reverse Stock Split, each certificate representing pre-Reverse Stock Split shares of our common stock will be deemed for all corporate purposes to evidence ownership of post-Reverse Stock Split shares.
SHAREHOLDERS SHOULD NOT DESTROY ANY SHARE CERTIFICATE(S) AND SHOULD NOT SUBMIT ANY SHARE CERTIFICATE(S) UNTIL REQUESTED TO DO SO.
Material U.S. Federal Income Tax Consequences of the Reverse Stock Split
The following is a summary of certain material United States federal income tax consequences of the Reverse Stock Split to a shareholder that is a “U.S. Holder,” as defined below. This summary does not purport to be a complete discussion of all of the possible federal income tax consequences of the Reverse Stock Split and is included for general information only. Further, it does not address any state, local or non-U.S. income or other tax consequences, including gift or estate taxes and the Medicare contribution tax on net investment income. Also, it does not address the tax consequences to shareholders that are subject to special tax rules, such as banks, insurance companies, regulated investment companies, personal holding companies, non-U.S. entities, nonresident alien individuals, broker-dealers, tax-exempt entities, shareholders that received common stock as compensation for services or pursuant to the exercise of an employee stock option, or shareholders who have held, or will hold, stock as part of a straddle, hedging or conversion transaction for federal income tax purposes. If a partnership holds our common stock, the tax treatment of a partner will generally depend on the status of the partner and upon the activities of the partnership. If you are a partner in a partnership holding our common stock, you are encouraged to consult your tax advisor. This summary also assumes that you are a U.S. Holder who has held, and will hold, shares of common stock as a “capital asset,” as defined in the Internal Revenue Code of 1986, as amended (the “Code”), i.e., generally, property held for investment. Finally, the following discussion does not address the tax consequences of transactions occurring prior to or after the Reverse Stock Split (whether or not such transactions are in connection with the Reverse Stock Split), including, without limitation, the exercise of options or rights to purchase common stock in anticipation of the Reverse Stock Split.
The tax treatment of a shareholder may vary depending upon the particular facts and circumstances of such shareholder. You should consult with your own tax advisor with respect to the tax consequences of the Reverse Stock Split. As used herein, the term U.S. Holder means a shareholder that is, for federal income tax purposes: an individual who is a citizen or resident of the United States; a corporation or other entity taxed as a corporation created or organized in or under the laws of the United States or any state, including the District of Columbia; an estate the income of which is subject to federal income tax regardless of its source; or a trust that (i) is subject to the primary supervision of a U.S. court and the control of one of more U.S. persons or (ii) has a valid election in effect under applicable U.S. Treasury regulations to be treated as a U.S. person.
The following discussion is based on the Code, applicable U.S. Treasury regulations, judicial authority and administrative rulings and practice, all as of the date hereof. The Internal Revenue Service (“IRS”) could adopt a contrary position. In addition, future legislative, judicial, or administrative changes or interpretations could adversely affect the accuracy of the statements and conclusions set forth herein. Any such changes or interpretations could be applied retroactively and could affect the tax consequences described herein. No ruling from the IRS or opinion of counsel has been obtained or will be obtained in connection with the Reverse Stock Split.
9

The Reverse Stock Split is intended to constitute a “recapitalization” for U.S. federal income tax purposes. Accordingly, except for adjustments that may result from the treatment of fractional shares of common stock as described below, no gain or loss should be recognized by a U.S. Holder as a result of the Reverse Stock Split. The aggregate tax basis of the post-Reverse Stock Split shares received in the Reverse Stock Split (including any whole share received in exchange for a fractional share) will be the same as the shareholder’s aggregate tax basis in the pre-Reverse Stock Split shares exchanged therefor. A U.S. Holder’s holding period for the post-Reverse Stock Split shares will include the period during which such shareholder held the pre-Reverse Stock Split shares surrendered in the Reverse Stock Split. For purposes of the above discussion, holders who acquired different blocks of common stock at different times for different prices must calculate their basis and holding periods separately for each identifiable block of such stock exchanged in the Reverse Stock Split.
As noted above, fractional shares of common stock will not be issued in connection with the Reverse Stock Split. Shareholders who would otherwise be entitled to receive fractional shares because they hold a number of shares not evenly divisible by the final ratio will automatically be entitled to receive an additional share of common stock to round up to the next whole post-Reverse Stock Split share of common stock. The U.S. federal income tax consequences of the receipt of such an additional fraction of a share of common stock is not clear. A U.S. Holder who receives a whole share of common stock in lieu of a fractional share may recognize income or gain in an amount not to exceed the excess of the fair market value of such share over the fair market value of the fractional share to which such shareholder was otherwise entitled. U.S. holders should consult their tax advisors regarding the U.S. federal income tax and other tax consequences of fractional shares being rounded to the next whole share.
U.S. Holders will be required to provide their social security or other taxpayer identification numbers (or, in some instances, additional information) to the exchange agent in connection with the Reverse Stock Split to avoid backup withholding requirements that might otherwise apply. This information is generally provided byon IRS Form W-9 or a substitute form. Failure to provide such information may result in backup withholding at a rate of 24%.
THE PRECEDING DISCUSSION IS INTENDED ONLY AS A SUMMARY OF CERTAIN FEDERAL U.S. INCOME TAX CONSEQUENCES OF THE REVERSE STOCK SPLIT AND DOES NOT PURPORT TO BE A COMPLETE ANALYSIS OR DISCUSSION OF ALL POTENTIAL TAX EFFECTS RELEVANT THERETO. YOU SHOULD CONSULT YOUR OWN TAX ADVISORS AS TO THE PARTICULAR FEDERAL, STATE, LOCAL, NON-U.S. AND OTHER TAX CONSEQUENCES OF THE REVERSE STOCK SPLIT IN LIGHT OF YOUR SPECIFIC CIRCUMSTANCES.
Rights of Appraisal
Under North Carolina law, there are no appraisal rights with respect to the Proposed Amendment to be voted upon at the Special Meeting.
Vote Required for Approval
The approval of the Reverse Stock Split Proposal requires the affirmative vote of a majority of the issued and outstanding shares of common stock. Abstentions and broker-non-votes will have the same effect as a vote “AGAINST” the Reverse Stock Split Proposal.
Board Recommendation
The Board recommends that the shareholders vote “FOR” the Reverse Stock Split Proposal.
10

PROPOSAL 2

ADJOURNMENT TO SOLICIT ADDITIONAL PROXIES
The Adjournment Proposal
The Board is seeking shareholder approval of one or more adjournments to the Special Meeting to a later date or dates, if necessary, to permit further solicitation of proxies if there are not sufficient votes at the time of the Special Meeting cast in favor of the Reverse Stock Split Proposal or to constitute a quorum.
If, at the Special Meeting, the number of shares present or represented and voting to approve the Reverse Stock Split Proposal is not sufficient to approve such proposal, or if a quorum is not present, the Board currently intends to move to adjourn the Special Meeting to enable the Board to solicit additional proxies for the approval of the Reverse Stock Split Proposal or if there is not a quorum, as applicable.
In the Adjournment Proposal, we are asking our Bylaws. shareholders to authorize the holder of any proxy solicited by the Board to vote in favor of granting discretionary authority to the Board to adjourn the Special Meeting to another time and place for the purpose of soliciting additional proxies. If the shareholders approve the Adjournment Proposal, the Board could adjourn the Special Meeting and any adjourned session of the Special Meeting and use the additional time to solicit additional proxies, including the solicitation of proxies from shareholders who have previously voted. If the shareholders do not approve this proposal, the Chairman of the Special Meeting may exercise discretionary authority to adjourn the Special Meeting, as necessary.
Vote Required for Approval
The Adjournment Proposal will be approved if the affirmative votes cast “FOR” the proposal at the Special Meeting exceed the negative votes cast “AGAINST” such proposal. Abstentions and broker non-votes will have no effect on the Adjournment Proposal.
Board Recommendation
The Board recommends that the shareholders vote “FOR” the Adjournment Proposal.
11

SECURITY OWNERSHIP OF MANAGEMENT AND CERTAIN BENEFICIAL OWNERS
The following table sets forth information with respect to the beneficial ownership of common stock as of March 26, 2024 by (i) each person known by us to own beneficially more than five percent of our Company’s outstanding shares of common stock; (ii) each director and director nominee of our Company; (iii) each named executive officer of our Company; and (iv) all current directors and executive officers as a group. Except as indicated in the footnotes to this table and pursuant to applicable community property laws, to our knowledge, each shareholder named in the table has sole voting and investment power with respect to the shares set forth opposite such shareholder’s name.
Name and Address of Beneficial Owner(1)
Number of Shares
Beneficially
Owned(2)
Percent of
Class
Carlos Daniel Valadez(3)
c/o Law Offices of Ryan Reiffert, PLLC
8118 Datapoint Dr., San Antonio, TX 78229
1,789,133
5.9%
Ollin B. Sykes(4)
3,347,956
11.0
Don O’Connell(5)
1,320,450
4.4
Neal I. Goldman(6)
1,312,816
4.3
Anne M. Butler(7)
682,907
2.3
Clint J. Pete(8)
454,969
1.5
Benedetta Casamento(9)
343,902
1.1
Directors and Executive Officers as a Group (6 persons)(10)
7,463,000
24.6
(1)
Unless otherwise indicated, the address of each person is 170 Southport Drive, Morrisville, North Carolina 27560.
(2)
Based on 30,344,955 shares of common stock outstanding on March 26, 2024. The number and percentage of shares beneficially owned is determined in accordance with Rule 13d-3 of the Exchange Act and the information is not necessarily indicative of beneficial ownership for any other purpose. Under such rule, beneficial ownership includes any shares as to which the person has sole or shared voting power or investment power and also any shares that the person has the right to acquire within 60 days of March 26, 2024 through the exercise of any stock options or other rights. Any shares that a person has the right to acquire within 60 days are deemed to be outstanding for the purpose of computing the percentage ownership of such person but are not deemed outstanding for the purpose of computing the percentage ownership of any other person.
(3)
Based on a Schedule 13D/A filed on May 16, 2023 with the SEC. Mr. Valadez has sole voting power and dispositive power over 1,789,133 shares.
(4)
Includes (i) 180,527 shares owned by Mr. Sykes’s spouse, over which Mr. Sykes may be deemed to have shared voting and investment power; (ii) 68,231 shares subject to options exercisable within 60 days of March 26, 2024; (iii) 1,236,898 shares held by the Sykes & Company PA 401(k) Profit Sharing Plan UA January 1, 1985, of which Mr. Sykes is the co-trustee; and (iv) 1,862,300 shares held in a margin account.
(5)
Includes (i) 464,464 shares jointly owned with Mr. O’Connell’s spouse, over which Mr. O’Connell has shared voting and investment power; and (ii) 600,000 shares subject to options exercisable within 60 days of March 26, 2024.
(6)
Includes 75,054 shares subject to options exercisable within 60 days of March 26, 2024.
(7)
Includes (i) 319,672 shares subject to options exercisable within 60 days of March 26, 2024.
(8)
Includes (i) 170,000 shares subject to options exercisable within 60 days of March 26, 2024.
(9)
Includes (i) 112,873 shares subject to options exercisable within 60 days of March 26, 2024. and (ii) 20,600 shares owned by Ms. Casamento’s spouse, over which Ms. Casamento may be deemed to have shared voting and investment power.
(10)
Includes (i) 1,345,830 shares subject to options exercisable within 60 days of March 26, 2024.
12

OTHER MATTERS
The Board of Directors establishes corporate policies and strategies and supervisesknows of no other business which will be presented to the implementation and executionSpecial Meeting. If any other business is properly brought before the Special Meeting, proxies will be voted in accordance with the judgment of those policies and strategies by our officers and employees. The directors are kept informedthe persons named therein.
SHAREHOLDER PROPOSALS
Under certain conditions, shareholders may request us to include a proposal for action at a forthcoming meeting of our operations at meetings ofshareholders in the Board of Directors, through reports and analyses prepared by our management, and in discussions with our management.

Our Bylaws currently provide that the Board of Directors shall consist of not less than five nor more than 10 members and that at any time that it consists of nine or more members, the terms shall be staggered. The five persons named below have been recommended by our Nominating and Governance Committee and approved by the Board of Directorsproxy materials for such meeting. All shareholder proposals intended to be nominated as candidates to serve on the Board of Directors until thepresented at our 2024 Annual Meeting of Shareholders or until his or her successor is elected and qualified, or until his or her death, resignation, removal, or disqualification or until there is a decreasemust be received by us no later than June 29, 2024 for inclusion in the number of directors. The age and a brief biographical description of each director nominee are set forth below. The information appearing below and certain information regarding beneficial ownership of securities by such nominees contained in this proxy statement has been furnishedand proxy card relating to us bysuch meeting. In addition, if a shareholder desires to make a proposal from the nominees. Each nominee for director has indicated that he or she is willing and able to serve as a director if elected. However, if any nominee should become unable to serve or for good cause will not serve, the proxies appointed for the Annual Meeting will vote for such other nominees and substitute nominees as designated by the Board of Directors.

Nominees for Election as Directors

NameAgePosition(s) with Charles & Colvard, Ltd.Director Since
Neal I. Goldman79Chairman of the Board of DirectorsJune 2014
Anne M. Butler74DirectorJune 2012
Benedetta Casamento57DirectorMay 2017
Don O’Connell58Director, President and Chief Executive OfficerJune 2020
Ollin B. Sykes72DirectorMay 2008

Neal I. Goldman has served as a director offloor during our Company since June 2014, as Executive Chairman of the Board of Directors from January 2015 until August 2017, and as Chairman of the Board of Directors since August 2017. Mr. Goldman has served as President of Goldman Capital Management, Inc., an investment advisory firm, since he founded the firm in 1985. Prior to that, Mr. Goldman was an analyst and portfolio manager at Shearson/American Express Inc. Mr. Goldman served on the Board of Directors of Blyth, Inc. (NYSE: BTH), a multi-channel company focused on the direct-to-consumer market, and includes in its portfolio two direct sales companies, PartyLite Gifts, Inc. (“PartyLite”), and ViSalus Sciences, from 1991 to August 2014. From August 2012 through November 2020, Mr. Goldman served on the Board of Imageware Systems, Inc. (OTCQB: IWSY), a leading company in the emerging market for biometrically enabled software-based identity management solutions. In August 2018, he was appointed to the Board of Directors of iPass Inc. (Nasdaq:IPAS), a leading provider of global mobile connectivity, and served until that company was acquired in February 2019. Mr. Goldman has also served on the Board of Directors of Koil Energy Solutions, Inc. (OTCQB: KLNG) (previously Deep Down Inc. (OTCQB: DPDW)), an oilfield services company specializing in complex deepwater and ultra-deepwater oil production distribution system support services, since April 2019. Mr. Goldman has also served on the Board of Directors of Milestone Scientific Inc. (NYSE American: MLSS), a biomedical technology research and development company, since April 2019, and was appointed Chairman of its Board of Directors in January 2023. Our Board of Directors has determined that Mr. Goldman’s extensive experience with the investment advisory industry, including his service as President of Goldman Capital Management, Inc., qualifies him to serve on the Board of Directors.

Anne M. Butler has served as a director of our Company since June 2012. Since January 2012, Ms. Butler has served as CEO of Butler Advisors, a consulting firm specializing in strategic and operational advising to private equity, venture capital, and institutional investors on direct selling acquisitions and management. As a leading executive in the direct selling industry, Ms. Butler has successfully run global businesses for Avon Products, Inc. (“Avon”), Aloette Cosmetics, Mary Kay Cosmetics, Inc. (“Mary Kay”), and PartyLite. Ms. Butler started her career with Avon, where she held a variety of progressive assignments across marketing, sales, new market expansion, and new business development while serving as Director of Marketing in Spain, Vice President of Avon Fashions in Brazil, and as General Manager, Avon Fashions for Continental Europe. At Mary Kay, Ms. Butler served as President of the Western and Central Europe business and subsequently successfully expanded the European business at PartyLite where she advanced to President, PartyLite International. Ms. Butler was appointed Worldwide President of PartyLite in May 2007, a position she held until January 2012. She also served on the Board of ViSalus Sciences, the weight loss and fitness direct sales subsidiary of Blyth, Inc. Ms. Butler served on the Board of AdvoCare International from July 2015 to June 2019. Our Board of Directors has determined that Ms. Butler’s leadership in several public companies, as well as her background in marketing and global operations, qualifies her to serve on the Board of Directors.

4

Benedetta Casamento has served as a director of our Company since May 2017. Since August 2017, Ms. Casamento has served as a Business Consultant specializing in finance, business operations, and financial planning and analysis. Since May 2022, Ms. Casamento has served on the Board of Directors of Milestone Scientific Inc. (NYSE: MLSS), a biomedical technology research and development company for diagnostic and therapeutic injection technologies and devices. Ms. Casamento previously served as Chairman and President of Allyke, Inc., an artificial intelligence company creating digital imagery insights for retail and other industries, from June 2016 to August 2017. From December 2014 to April 2016, she served as Chief Executive Officer of Calypso St. Barth, a luxury boutique retailer of women’s apparel and accessories. Prior to her role as CEO at Calypso St. Barth, Ms. Casamento served as a consultant to private equity firms with portfolio interests in retail and fashion from July 2012 to December 2014. Ms. Casamento previously served as Executive Vice President, Finance & Operations of The Talbots, Inc. (“Talbots”), a specialty retailer and direct marketer of women’s apparel, accessories, and shoes, from March 2009 to July 2012. Prior to joining Talbots, Ms. Casamento served in various leadership roles within Liz Claiborne Inc. from February 1999 to November 2008, culminating in her position as President of Liz Claiborne Brands. Ms. Casamento started her career at Saks Fifth Avenue. Our Board of Directors has determined that Ms. Casamento’s extensive fashion and retail experience, as well as her background in accounting and finance, qualifies her to serve on the Board of Directors.

Don O’Connell was appointed as our President and Chief Executive Officer and as a director of our Company on June 1, 2020. Mr. O’Connell previously served as our Chief Operating Officer and Senior Vice President, Supply Chain & Distribution, since May 23, 2017, and our Senior Vice President, Supply Chain & Distribution from March 2016 to May 2017. Prior to joining our Company, Mr. O’Connell served as Executive Vice President Operations & Global Jewelry Business Solutions at OFT Investment & Management Group, a fine jewelry solutions and services group, from February 2012 to March 2016. Prior to his employment with OFT Investment Management Group, Mr. O’Connell spent seven years with the Richline Group, LLC, a wholly owned subsidiary of Berkshire Hathaway, as Vice President, Operations & Procurement, both Foreign & Domestic. Prior to that, he was Vice President, Operations at Aurafin’s gem group division in Tamarac, FL and La Paz, Bolivia as well as Vice President, Manufacturing & Contracting with OCON Enterprise. Our Board of Directors has determined that Mr. O’Connell’s extensive operations and distribution background working with gemstone and fine jewelry companies qualifies him to serve on the Board of Directors.

Ollin B. Sykes has served as a director of our Company since May 2008. Since 1984, he has served as the President of Sykes & Company, P.A., a regional accounting firm specializing in accounting, tax, and financial advisory services. Mr. Sykes earned his Bachelor of Science degree in accounting at Mars Hill College and is a Certified Public Accountant, a Certified Information Technology Professional, and a Certified Management Accountant. Mr. Sykes served as a director of Hampton Roads Bankshares, Inc. (Nasdaq: HMPR), a financial holding company operating in North Carolina, Maryland eastern shore, and Virginia, from December 2008 until December 31, 2010. He also served as a director of Bank of Hampton Roads, a wholly owned subsidiary of Hampton Roads Bankshares, Inc. from January 2011 to June 2016. Our Board of Directors has determined that Mr. Sykes’s background in accounting and finance and his accounting certifications qualify him to serve on the Board of Directors.

THE BOARD OF DIRECTORS RECOMMENDS A VOTE “FOR” THE ELECTION OF EACH OF THE DIRECTOR NOMINEES.

5

Board Diversity

The Board believes that it is important to consider diversity of race, ethnicity, gender, sexual orientation, religion, age, education, cultural background and professional experiences in evaluating board candidates in order to provide practical insights and diverse perspectives. The Board Diversity Matrix, below, provides the diversity statistics for our Board.

Board Diversity Matrix (As of October 17, 2023)
Total Number of Directors5
 FemaleMaleNon-BinaryDid Not Disclose Gender
Part I: Gender Identity    
Directors2300
Part II: Demographic Background    
White2300

CORPORATE GOVERNANCE MATTERS

Independent Directors

In accordance with the listing rules of The Nasdaq Stock Market LLC (“Nasdaq”), our Board of Directors must consist of a majority of “independent directors,” as determined in accordance with Nasdaq Rule 5605(a)(2). The Board of Directors has determined that current directors Ms. Butler, Ms. Casamento, Mr. Goldman, and Mr. Sykes are independent directors in accordance with applicable Nasdaq listing rules. The Board of Directors performed a review to determine the independence of its members and made a subjective determination as to each member that no transactions, relationships, or arrangements exist that, in the opinion of the Board of Directors, would interfere with the exercise of independent judgment in carrying out the responsibilities of a director of our Company. In making these determinations, the Board of Directors reviewed the information provided by the directors with regard to each individual’s business and personal activities as they may relate to us and our management.

Meetings of the Board of Directors

Pursuant to our Corporate Governance Standards, all directors are expected to attend meetings of the Board of Directors and their assigned committees. The Board of Directors meets on a regularly scheduled and as needed basis and met 21 times during fiscal 2023. Each incumbent director attended 75% or more of the aggregate of the number of meetings of the Board of Directors held during the period that the individual was a director and the number of meetings of committees on which that director served that were held during the period of that director’s service. We also expect all directors to attend each annual meeting of shareholders. Five directors, comprising all of the nominees for election at the 20222024 Annual Meeting of Shareholders, attendedeven if such proposal is not to be included in our proxy statement, the 2022Bylaws provide that the shareholder must deliver or mail timely written notice of the proposal to our Corporate Secretary. Notice will be considered timely if it is delivered or mailed to and received at our principal executive office between July 29, 2024 and August 28, 2024, which is not more than 90 calendar days and not fewer than 60 calendar days prior to the one year anniversary of the date of the Notice of Annual Meeting of Shareholders.

Board Leadership Structure

Currently, Mr. O’Connell serves as our Chief Executive Officer and Mr. Goldman serves as our ChairmanShareholders for the immediately preceding annual meeting. In the event that no annual meeting was held in the previous year or the date of the Boardannual meeting has been advanced by more than 30 days or delayed by more than 60 days from the one year anniversary of Directors. The Chairman is not an employeethe previous year’s annual meeting of our Company. The Board of Directors has determined that it is in the best interest of our Company for our Chairmanshareholders, notice by a shareholder to be an independent director at this time. The Boardtimely must be received no earlier than the 90th day prior to such annual meeting and not later than the 60th day prior to such annual meeting or the close of Directors believes that having an independent Chairman furthersbusiness on the Board of Directors’ goal of providing effective, independent leadership and oversight of our Company. The Chairman’s responsibilities include establishing Board meeting agendas in collaboration with our Chief Executive Officer and presiding at meetings10th day following the day on which notice of the Board of Directors and shareholders. The Chairman is also tasked with working closely with senior management of our Company regarding business strategy and the effective achievement of objectives and strategy following presentation to and approval by the Board of Directors. The Chief Executive Officer has general supervision, direction, and controlmeeting was mailed or public disclosure of the business and affairs of our Company in the ordinary course of its business.

To ensure free and open discussion and communication among the non-management directors, such directors meet regularly in executive session in conjunction with regularly scheduled meetingsdate of the Board of Directors. The director who presides at these meetings is chosen by the independent directors. Executive sessions of the independent directors are to occur at least four times a year.

6meeting was first made, whichever occurs first.

Board’s Role in Risk Oversight

We operate in a complex environment and are subject to a number of significant risks. The Board of Directors works with our senior management to manage the various risks we face. The role of the Board of Directors is one of oversight of our risk management processes and procedures; the role of our management is to implement those processes and procedures on a daily basis and to identify, manage, and mitigate the risks that we face. As part of its oversight role, the Board of Directors regularly discusses, both with and without management present, our risk profile and how our business strategy effectively manages and leverages the risks that we face.

To facilitate its oversight of our Company, the Board of Directors has delegated certain functions (including the oversight of risks related to these functions) to Board committees. The Audit Committee reviews and discusses with management our major financial risk exposures and the steps management has taken to monitor and control such exposures, the Compensation Committee evaluates the risks presented by our compensation programs and analyzes these risks when making compensation decisions, and the Nominating and Governance Committee evaluates whether the composition of the Board of Directors is appropriate to respond to the risks that we face. The roles of these committees are discussed in more detail below.

Although the Board of Directors has delegated certain functions to various committees, each of these committees regularly reports to and solicits input from the full Board of Directors regarding its activities. These discussions enable the Board of Directors to monitor our risk exposure and evaluate our risk mitigation efforts.

Anti-Hedging Policy

Our insider trading policy prohibits all directors, officers, and employees of our Company, their family members, and any agents, consultants, or other outsiders who are designated as insiders for purposes of the policy from trading in any interest or position relating to the future price of our Company’s securities, such as a put, call, or short sale. In addition, the policy prohibits engaging in hedging or monetization transactions with respect to Company securities, including zero-cost collars, forward sale contracts or any other similar instruments.

Standing Committees of the Board of Directors

The Board of Directors has established an Audit Committee, a Compensation Committee, and a Nominating and Governance Committee as standing committees of the Board of Directors. Each of these committees is governed by a formal written charter approved by the Board of Directors, copies of which are available on our website at https://ir.charlesandcolvard.com/governance/corporate-governance. Each committee is composed solely of independent directors. The following is a brief description of the responsibilities of each of these standing committees and their composition.

Audit Committee

The Audit Committee represents and assists the Board of Directors in its general oversight of our Company’s accounting and financial reporting processes, audits of the financial statements, and internal control and audit functions. The Audit Committee has the authority to, among other things, (i) appoint an independent registered public accounting firm to serve as our external auditor; (ii) review and discuss with such auditor the scope, timing, and results of its audit; (iii) review and discuss with management and the independent registered public accounting firm our internal control over financial reporting and related reports; (iv) review and approve in advance all “related person” transactions, as that term is defined in Item 404 of Regulation S-K; and (v) review our annual financial statements and approve their inclusion in our Annual Report on Form 10-K. The Audit Committee, which held 5 meetings in fiscal 2023, is currently composed of Ms. Casamento (Chairperson), Ms. Butler, Mr. Goldman, and Mr. Sykes. The Audit Committee was established in accordance with Section 3(a)(58)(A) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

The Board of Directors has determined that each of the members of the Audit Committee is an independent director in accordance with applicable Nasdaq listing rules and the additional independence rules for audit committee members promulgated by the SEC. Each member is able to read and understand fundamental financial statements, including our Company’s balance sheet, statement of operations, and cash flow statement. The Board of Directors has determined that Ms. Casamento, Ms. Butler, Mr. Goldman, and Mr. Sykes are “audit committee financial experts” as defined in Item 407(d)(5) of Regulation S-K promulgated by the SEC.

7

Compensation Committee

The Compensation Committee carries out the overall responsibility of the Board of Directors relating to executive compensation, evaluation, and development. The Compensation Committee has the authority to, among other things, (i) review and approve the corporate goals and objectives with respect to the compensation of our Chief Executive Officer and set the Chief Executive Officer’s annual compensation, including salary, bonus, incentive compensation, and equity compensation; (ii) review and approve the evaluation process and compensation structure for our officers and approve their annual compensation, including salary, bonus, incentive compensation, and equity compensation, and any special or supplemental benefits; (iii) review, approve and when appropriate, recommend to the Board of Directors for approval, incentive and equity compensation plans, which includes the ability to adopt, amend and terminate such plans; and (iv) evaluate and make recommendations to the Board of Directors concerning the compensation for directors, including if applicable, equity-based compensation. Each of the members of the Compensation Committee is an independent director in accordance with Nasdaq listing rules. The Compensation Committee, which held 10 meetings in fiscal 2023, is currently composed of Ms. Butler (Chairperson), Ms. Casamento, Mr. Goldman, and Mr. Sykes. Although the Compensation Committee may delegate authority to subcommittees to fulfill its responsibilities when appropriate, no such authority was delegated during fiscal 2023.

The Compensation Committee has the authority under its charter to retain outside consultants or advisors as it deems necessary or advisable to assist in carrying out its responsibilities. In setting executive compensation for fiscal 2023, the Compensation Committee did not engage an outside compensation consultant. It received input from the Chief Executive Officer in setting executive compensation, including receiving input regarding the structure and potential payout amounts under the 2023 Program (as defined below), for the Chief Financial Officer.

Nominating and Governance Committee

The Nominating and Governance Committee is responsible for, among other things, (i) screening and recommending qualified candidates for election and appointment to the Board of Directors; (ii) recommending to the Board of Directors from time to time an appropriate organizational structure (including size and composition) for the Board of Directors; (iii) monitoring the independence of the Board of Directors and ensuring that the requisite number of directors serving on committees of the Board of Directors meet applicable independence requirements and assisting the Board of Directors in making related determinations; (iv) reviewing from time to time the appropriate qualifications, skills, and characteristics required of directors; (v) developing procedures to receive and evaluate Board of Directors nominations received from shareholders and other third parties; (vi) periodically reviewing and reassessing the adequacy of our Company’s corporate governance; conflicts of interest; and business ethics policies, principles, codes of conduct, and guidelines; and formulating and recommending any proposed changes to the Board of Directors; and (vii) conducting an annual review of the effectiveness of the Board of Directors and its committees and presenting its assessment to the full Board of Directors. Each of the members of the Nominating and Governance Committee is an independent director in accordance with Nasdaq listing rules. The Nominating and Governance Committee, which held 2 meetings in fiscal 2023, is currently composed of Ms. Butler (Chairperson), Ms. Casamento and Mr. Goldman.

Director Nominations

Our Bylaws contain provisions that address the process by which a shareholder may nominate an individual to stand for election to the Board of Directors at our 2024 Annual Meeting of Shareholders. These provisions state that nominations for election as a director must be made in writing and be delivered to or mailed and received at our principal executive office between July 29, 2024 and August 28, 2024, which is not more than 90 calendar days and not fewer than 60 calendar days prior to the one year anniversary of the date of the Notice of Annual Meeting of Shareholders for the immediately preceding annual meeting. In the case of a special meeting, no annual meeting was held in the previous year, or an annual meeting that is called for a date that is not within 30 days before or 60 days after the anniversary date of the immediately preceding annual meeting, notice must be received no earlier than 90 days prior to such annual meeting or special meeting and no later than 60 days prior to such annual meeting or special meeting, or the close of business on the 10th day following the day on which notice of the meeting was mailed or public disclosure of the date of the meeting was made, whichever occurs first. The Corporate Secretary will provide the Nominating and Governance Committee with a copy of any such notification received by us from a shareholder purporting to nominate a candidate for election as a director. Any shareholder wishing to submit a nomination for a director of our Company should send the nomination to the Corporate Secretary, Charles & Colvard, Ltd., 170 Southport Drive, Morrisville, North Carolina 27560.

8

When submitting a nomination to us for consideration by the Nominating and Governance Committee, a shareholder must provide the following minimum information for each director nominee: (i) the name, age, business address, and residence address of such person, (ii) the principal occupation or employment of such person, (iii) the class and number of shares of our Company that are beneficially owned by such person, (iv) a description of all arrangements or understandings between the shareholder (or the beneficial owner, if any, on whose behalf such nomination is made) and each nominee and any other person or persons (naming such person or persons) pursuant to which the nominations are to be made by the shareholder, (v) any other information relating to such person that is required to be disclosed in solicitations of proxies for elections, or is otherwise required, in each case pursuant to Regulation 14A under the Exchange Act, (including, without limitation, such person’s written consent to being named in the proxy statement, if any, as a nominee and to serving as a director if elected), and (vi) such additional information relating to such person as is deemed sufficient by the Board of Directors to establish that the person meets all minimum qualification standards or other criteria to serve as a director as may have been established by the Board of Directors or applicable law or listing standard. The shareholder also must provide the name and address, as they appear on our Company’s books, of the shareholder proposing such business and the beneficial owner, if any, on whose behalf such proposal is made; the class and number of shares of our Company that are beneficially owned by the shareholder and the beneficial owner on whose behalf the proposal is made; any material interest, direct or indirect, of the shareholder and such beneficial owner in such business; and a representation that the shareholder is a holder of record of shares of our Company entitled to vote at the meeting and intends to appear in person or by proxy at the meeting. Shareholder nominations for a director must be made in a timely manner and otherwise in accordance with our Bylaws and applicable law. In addition, shareholders who intend to solicit proxies in support of director nominees other than the Board of Directors’ nominees in accordance with Rule 14a-19 under the Exchange Act must provide notice that sets forth the information required by the Company’s Bylaws and Rule 14a-19(b), which notice must be delivered to the Corporate Secretary within the applicable timeframes set forth in the Company’s Bylaws described above.

It is the policy of our

13

WHERE YOU CAN FIND ADDITIONAL INFORMATION
The Company files annual, quarterly and the Nominating and Governance Committee to evaluate suggestions concerning possible candidates for election to the Board of Directors submitted to us, including those submitted by members of the Board of Directors, shareholders, and third parties. Criteria used by the Nominating and Governance Committee in its evaluation of all candidates for nomination are set forth in our Corporate Governance Standards and include, but are not limited to (i) judgment, character, expertise, skills, and knowledge useful to the oversight of our business; (ii) diversity of viewpoints, backgrounds, ages, experiences,current reports, proxy statements and other demographics; (iii) business or other relevant experience; and (iv) the extent to which the interplay of the candidate’s expertise, skills, knowledge, and experience with that of other members of the Board of Directors will build a Board of Directors that is effective, collegial, and responsive to the needs of our Company. After this evaluation process is concluded, the Nominating and Governance Committee recommends nominees to the Board of Directors for further consideration and approval.

No fees have been paid to any third party to identify or evaluate or assist in identifying or evaluating potential nominees.

Shareholder Communicationinformation with the Board

As set forth in our Corporate Governance Standards, it is the policy of our CompanySEC. The SEC maintains an internet web site that contains reports, proxy and the Board of Directors to encourage freeinformation statements, and open communication between shareholders and the Board of Directors. Any shareholder wishing to communicateother information regarding issuers, including us, that file electronically with the BoardSEC. The public can obtain any documents that we file electronically with the SEC at http://www.sec.gov.

You may obtain additional copies of Directors should sendthis proxy statement, at no cost, and you may ask any communicationquestions you may have about the Reverse Stock Split Proposal or the Adjournment Proposal by contacting us at the following address or email:
Charles & Colvard, Ltd.
Attention: Corporate Secretary
170 Southport Drive
Morrisville, North Carolina 27560
Phone: Call (919) 468-0399 and ask to speak to the Corporate Secretary Charles
You may also obtain these documents at no cost by requesting them in writing or by telephone from the Company’s proxy solicitation agent at the following address and telephone number:
Alliance Advisors
200 Broadacres Drive, 3rd Floor
Bloomfield, New Jersey 07003
833-501-4701
CTHR@allianceadvisors.com
In order to receive timely delivery of the documents in advance of the special meeting, you must make your request for information no later than April 30, 2024 (one week prior to the date of the special meeting).
REFERENCES TO OUR WEBSITE ADDRESS
References to our website address throughout this proxy statement and the accompanying materials are for informational purposes only, or to fulfill specific disclosure requirements of the SEC’s rules. These references are not intended to, and do not, incorporate the contents of our website by reference into this proxy statement or the accompanying materials.
14

APPENDIX A
ARTICLES OF AMENDMENT TO
RESTATED ARTICLES OF INCORPORATION OF
CHARLES & Colvard, Ltd., 170 Southport Drive, Morrisville,COLVARD, LTD.
Pursuant to Section 55-10-06 of the North Carolina 27560. Any such communication mustBusiness Corporation Act, the undersigned corporation hereby submits these Articles of Amendment for the purpose of amending its Restated Articles of Incorporation:
1.
The name of the corporation is Charles & Colvard, Ltd.
2.
The Restated Articles of Incorporation of the corporation are hereby amended as follows:
That Article II of the Restated Articles of Incorporation, as amended to date, be and hereby is further amended by deleting the first paragraph thereof and inserting in writingits place the following:
“The Corporation is authorized to issue two (2) classes of capital stock to be designated, respectively, Common Stock (“Common Stock”) and must state thePreferred Stock (“Preferred Stock”). The total number of shares beneficially owned byof capital stock that the shareholder makingCorporation is authorized to issue is sixty million (60,000,000). The total number of shares of Common Stock the communication. Our Corporate Secretary will generally forward such communication to the full Board of Directors or to any individual director or directors to whom the communication is directed unless the communication is unduly hostile, threatening, illegal, or similarly inappropriate, in which case the Corporate Secretary has theCorporation shall have authority to discardissue is fifty million (50,000,000), and the communication or take appropriate legal action regardingtotal number of shares of Preferred Stock the communication. This processCorporation shall have authority to issue is intended to provide shareholders one meansten million (10,000,000). The Common Stock shall have no par value per share, and the Preferred Stock shall have no par value per share.
At , Eastern Time, on , 2024 (the “Effective Date”), each share of communicating with directors and is not intended to be exclusive.

9

Codes of Conduct

The Board of Directors has adopted two separate codes of conduct: a Code of Ethics for Senior Financial Officers that applies to persons holding the offices of the Chief Executive Officer, Chief Financial Officer, Treasurer, and Principal Accounting Officer of our Company, and a Code of Business Conduct and Ethics that applies to all of our officers, directors, employees, agents, and representatives (including consultants, advisors, and independent contractors). Each code is available on our website at https://ir.charlesandcolvard.com/governance/corporate-governance. We intend to satisfy the disclosure requirement regarding any material amendment to a provision of either code that applies to the Chief Executive Officer, Chief Financial Officer, Treasurer, and Principal Accounting Officer by posting such information on our website. Any amendments or waivers of either code for any executive officer or director must be approved by the Board of Directors and will be publicly disclosed either by posting such amendment or waiver, along with the reasons for the waiver, on our website at https://ir.charlesandcolvard.com/governance/corporate-governance, by filing a Form 8-K with the SEC, or by issuing a press release in accordance with SEC and Nasdaq requirements.

CERTAIN TRANSACTIONS

Since July 1, 2021, we have not been a participant in or a party to any related person transactions requiring disclosure under the SEC’s rules.

AUDIT COMMITTEE REPORT

The Audit Committee is responsible for overseeing our overall financial reporting process. In fulfilling its responsibilities for the financial statements for fiscal 2023, the Audit Committee:

reviewed and discussed the audited financial statements for the fiscal year ended June 30, 2023 with management and BDO USA, P.C., Raleigh, NC; PCAOB ID: 243, our independent registered public accounting firm;

discussed with BDO USA, P.C. the matters required to be discussed by the applicable requirements of the Public Company Accounting Oversight Board (the “PCAOB”) and the SEC; and

received the written disclosures and the letter from BDO USA, P.C. required by applicable requirements of the PCAOB regarding BDO USA, P.C.’s communications with the Audit Committee concerning independence and has discussed with BDO USA, P.C. its independence.

Based on the Audit Committee’s review and discussions referred to above, the Audit Committee recommended to the Board of Directors that the audited financial statements be included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2023 for filing with the SEC.

This Report is submitted by the Audit Committee.

Ms. Benedetta Casamento, Chairperson

Ms. Anne M. Butler

Mr. Neal I. Goldman

Mr. Ollin B. Sykes

INFORMATION CONCERNING EXECUTIVE OFFICERS

Certain information regarding our executive officers is set forth below. Executive officers are appointed by the Board of Directors to hold office until their successors are duly appointed and qualified or until their resignation, retirement, death, removal or disqualification. The information appearing below and certain information regarding beneficial ownership of securities by certain executive officers contained in this proxy statement has been furnished to us by the executive officers. Information regarding Mr. O’Connell is included in the director nominee profiles set forth above.


Name
AgeTitleExecutive Officer Since
Don O’Connell58President and Chief Executive OfficerMay 2017
Clint J. Pete61Chief Financial Officer and TreasurerDecember 2016

Clint J. Pete was appointed as our Chief Financial Officer on May 23, 2017. Mr. Pete previously served as our Interim Chief Financial Officer from December 2016 to May 2017 and as our Corporate Controller from June 2016 to December 2016. Prior to joining our Company, Mr. Pete most recently served as Director of Business Planning for Oracle Corporation, a cloud application company, from June 2013 to May 2016. Prior to his employment with Oracle Corporation, Mr. Pete served as Business Unit Controller, Global Signaling Solutions of Tekelec, a telecommunications company, from May 2011 to May 2013. At Tekelec, Mr. Pete also previously served as Global Revenue Controller. Prior to his employment with Tekelec, Mr. Pete served as Vice President of Finance and Controllers at Qualex Inc., a Kodak company. Before joining Qualex Inc., Mr. Pete held various management positions at Ernst & Young, LLP, an international public accounting firm. Mr. Pete holds a Bachelor of Business Administration degree in Accounting and Finance from Texas Tech University and is a Certified Public Accountant.

10

EXECUTIVE COMPENSATION

The following tables and narrative discussion summarize the compensation we paid for services in all capacities rendered to us during the fiscal years ended June 30, 2023 and 2022 by our principal executive officer and all our “named executive officers.”

Fiscal 2023 Summary Compensation Table

Name and Principal Position Fiscal Year  
Salary
($)
  
Bonus
($)
  
Stock Awards
($)(1)
  

Non-Equity

Incentive Plan

 Compensation

($)

  
All Other
Compensation
($)
  
Total
($)
 
                      
Don O’Connell 2023
  $
357,269
  $
25,324
(2)
 $
94,088
(3)
 $
53,156
(4) $
48,531
(5) $
578,368
 
President and Chief Executive Officer 2022   346,673   91,163(6)  531,205(7)  175,959(8)  36,214(9)  1,181,214 
Clint J. Pete 2023   270,950  -   47,044(10)  26,902(11)  28,007(12)  372,903 
Chief Financial Officer and Treasurer 2022   263,074   -   241,501(13)  87,980(14)  16,672(15)  609,227 

(1)The amounts shown in these columns reflect the aggregate grant date fairCommon Stock, no par value computed in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Topic 718, Compensation – Stock Compensation (“ASC Topic 718”), of the stock awards, excluding the effect of any estimated forfeitures, granted to each of our named executive officers. The assumptions made in determining these values are set forth in Note 12 to our consolidated financial statements included in our Annual Report on Form 10-K for the year ended June 30, 2023 filed with the SEC on October 12, 2023.
(2)Reflects a discretionary cash bonus paid to Mr. O’Connell on October 28, 2022.
(3)Reflects the equity portion of the performance-based award granted to Mr. O’Connell under the 2023 Program (as defined below). Pursuant to FASB ASC Topic 718, the aggregate grant date fair value of the equity portion of this award was $191,794 including $67,128 in phantom stock settled only in cash, assuming that the highest level of performance conditions had been achieved. As a result of the executive team’s performance in fiscal 2023 measured against the Company performance goals set forth in the 2023 Program, on October 13, 2023, the Compensation Committee determined a 0% achievement level of the Company’s financial goals, resulting in the cancellation and forfeiture by the Company’s executive team of all of the awards granted under the 2023 Program.
(4)Reflects the cash portion of the performance-based award granted to Mr. O’Connell under the 2022 Program.
(5)Includes $22,529 of housing allowance, $17,591 of 401(k) employer matching contributions, and $8,411 of long-term disability insurance and life insurance premiums.
(6)Reflects the cash component of a discretionary award granted under the 2018 Plan (as defined below) to Mr. O’Connell on September 13, 2021.
(7)Reflects the equity portion of the performance-based awards granted to Mr. O’Connell under the 2022 Program (as defined below), the 2021 Program (as defined below) and the 2018 Plan, including $144,611 in phantom stock settled only in cash granted under the 2022 Program. Pursuant to ASC Topic 718, the aggregate grant date fair value of the equity portion of this award was $665,487, including $191,610 in phantom stock settled only in cash, assuming that the highest level of performance conditions had been achieved. As a result of the executive team’s level of performance in fiscal 2022 measured against the Company and individual performance goals set forth in the 2022 Program, on September 5, 2022 the Compensation Committee determined a 75% achievement level of the Company’s shared financial goals, resulting in the cancellation and forfeiture by the Company’s executive team of certain of the awards granted under the 2022 Program. As a result of this decision, this amount would be reduced by $103,294, including $36,153 in phantom stock settled only in cash.
11

(8)Reflects the cash portion of the performance-based award granted to Mr. O’Connell under the 2021 Program.
(9)Includes $22,673 of housing allowance, $8,406 of 401(k) employer matching contributions, and $5,135 of long-term disability insurance and life insurance premiums.
(10)Reflects the equity portion of the performance-based award granted to Mr. Pete under the 2023 Program (as defined below). Pursuant to ASC Topic 718, the aggregate grant date fair value of the equity portion of this award was $95,897 including $33,564 in phantom stock settled only in cash assuming that the highest level of performance conditions had been achieved. As a result of the executive team’s performance in fiscal 2023 measured against the Company performance goals set forth in the 2023 Program, on October 13, 2023, the Compensation Committee determined a 0% achievement level of the Company’s financial goals, resulting in the cancellation and forfeiture by the Company’s executive team of all of the awards granted under the 2023 Program.
(11)Reflects the cash portion of the performance-based award granted to Mr. Pete under the 2022 Program.
(12)Includes $16,257 of 401(k) employer matching contributions and $11,750 of long-term disability insurance and life insurance premiums.
(13)Reflects the equity portion of the performance-based award granted to Mr. Pete under the 2022 Program and the 2021 Program, including $72,306 in phantom stock settled only in cash granted under the 2022 Program. Pursuant to ASC Topic 718, the aggregate grant date fair value of the equity portion of this award was $308,642, including $95,805 in phantom stock settled only in cash, assuming that the highest level of performance conditions had been achieved. As a result of the executive team’s level of performance in fiscal 2022 measured against the Company and individual performance goals set forth in the 2022 Program, on September 5, 2022 the Compensation Committee determined a 75% achievement level of the Company’s shared financial goals, resulting in the cancellation and forfeiture by the Company’s executive team of certain of the awards granted under the 2022 Program. As a result of this decision, this amount would be reduced by $51,647, including $18,076 in phantom stock settled only in cash.
(14)Reflects the cash portion of the performance-based award granted to Mr. Pete under the 2021 Program.
(15)Includes $5,259 of 401(k) employer matching contributions and $11,413 of long-term disability insurance and life insurance premiums.
12

Outstanding Equity Awards at 2023 Fiscal Year-End

    Option Awards Stock Awards 
Name Grant
Date
 

Number of Securities Underlying Unexercised Options (#) 

Exercisable 

 

Number of

Securities

Underlying Unexercised

Options (#) 

Unexercisable 

 
Option
Exercise
Price
($)
 Option
Expiration
Date
 Number
of shares
or units
of stock
that have
not
vested (#)
 Market value of shares or units of stock that have not vested ($) 

Equity 

incentive 

plan

awards:

Number of 

unearned 

shares,

units or

other

rights that

have not

vested 

(#) 

  

Equity 

incentive 

plan

awards:

Market

or payout

value of 

unearned 

shares,

units or

other

rights

that have

not vested 

($)(1) 

 

Don O’Connell 

 3/15/2016 50,000       - $1.44 3/15/2026       -      - -  - 
  5/23/2017 100,000 -  0.88 5/23/2027 - - -  - 
  6/1/2020 350,000 -  0.70 6/1/2030 - - -  - 
  11/7/2022 -
 -
  -
 -
 -

-

150,000(2)(3) 144,000(4)
Clint J. Pete 8/23/2016 20,000 -  1.29 8/23/2026 - - -  - 
  5/23/2017 100,000 -  0.88 5/23/2027 - - -  - 
  11/7/2022 - -  - - - - 75,000(2)(5) 72,000(6)

(1)The market value of shares of common stock and shares of phantom stock that have not vested is based on a price of $0.96 per share (the closing price of our common stock as reported by Nasdaq on June 30, 2023).
(2)

The restrictions on the stock award lapse on July 31, 2023, subject to achievement of performance goals and to the officer’s continued service to our Company as of such date. The level of achievement of the performance goals under the 2023 Program as determined by the Compensation Committee is 0% achievement and is discussed below under the heading “Fiscal 2023 Senior Management Equity Incentive Program.”

(3)

Includes 52,500 units of phantom stock settled only in cash.

(4)

Includes $50,400 in shares of phantom stock settled only in cash.

(5)

Includes 26,250 units of phantom stock settled only in cash.

(6)Includes $25,200 in shares of phantom stock settled only in cash.

13

Agreements Involving Named Executive Officers

Don O’Connell

We entered into an amended and restated employment agreement with Mr. O’Connell, effective as of June 1, 2020. The amended and restated employment agreement has a term of one year that renews automatically on an annual basis. Mr. O’Connell is entitled to receive such benefits as are made available to our other similarly-situated executive employees, including, but not limited to, life, medical, and disability insurance, as well as retirement benefits. Mr. O’Connell is also entitled to a monthly housing allowance of up to $1,700 per month as long as his primary residence remains outside of North Carolina and an annual aggregate amount of $15,000 per year for the costs of travel to such primary residence.

Pursuant to the employment agreement, if Mr. O’Connell’s employment is terminated by us without cause (as defined in the employment agreement), by Mr. O’Connell for good reason (as defined in the employment agreement), or if the term of the employment agreement expires following our notice of non-renewal, Mr. O’Connell will continue to receive his base salary at the time of termination for a period of one year from such termination, so long as he complies with certain covenants in the employment agreement. We also agreed to accelerate the vesting of all outstanding unvested equity awards held by Mr. O’Connell upon the occurrence of a change of control or termination without cause that occurs within six monthsshare, issued immediately prior to a change of control (as defined in the employment agreement), so long as he complies with certain covenants in the employment agreement. During Mr. O’Connell’s employment with usEffective Date will be automatically combined and for a period of one year following termination of his employment, Mr. O’Connell is prohibited from competing with us or attempting to solicit our customers or employees.

Clint J. Pete

We enteredconverted into an employment agreement with Mr. Pete, effective as of May 23, 2017, with a term of one year that renews automatically on an annual basis. Mr. Pete is entitled to receive such benefits as are made available to our other similarly-situated executive employees, including, but not limited to, life, medical, and disability insurance, as well as retirement benefits.

Pursuant to the employment agreement, if we experience a change of control (as defined in the employment agreement), and Mr. Pete’s employment is terminated within six months after such change of control by us without cause (as defined in the employment agreement) or by Mr. Pete for good reason (as defined in the employment agreement), Mr. Pete will continue to receive his base salary at the time of termination for a period of one year from such termination, so long as he complies with certain covenants in the employment agreement. In addition, Mr. Pete is entitled to receive six months of his base salary in the event we terminate him without cause not occurring within six months following a change of control or if the term of the employment agreement expires following our notice of non-renewal, so long as he complies with certain covenants in the employment agreement. We also agreed to accelerate the vesting of all outstanding unvested equity awards held by Mr. Pete upon the occurrencefraction of a changeshare of control or termination without cause not occurring within six months following a change of control, so long as he complies with certain covenants in the employment agreement. During Mr. Pete’s employment with us and for a period of one year following termination of his employment, Mr. Pete is prohibited from competing with us or attempting to solicit our customers or employees.

Termination and Change of Control Arrangements

In addition, the Charles & Colvard, Ltd. 2008Common Stock, Incentive Plan, as amended (the “2008 Plan”), and the Charles & Colvard, Ltd. 2018 Equity Incentive Plan (the “2018 Plan”) provide for adjustments to or accelerated vesting of equity awards under specified circumstances, as described below. The 2008 Plan expired (with respect to future grants) on May 26, 2018.

The 2008 Plan provides that, in the event of a change of control of our Company (as defined in the 2008 Plan), the Compensation Committee has sole discretion to determine the effect, if any, on an award, including, but not limited to, the vesting, earning, and/or exercisability of an award.

The 2018 Plan provides that in the event of a participant’s termination of continuous service without cause (as defined in the 2018 Plan) or for good reason (as defined in the 2018 Plan) during the six-month period following a change in control (as defined in the 2018 Plan), notwithstanding any provision of the 2018 Plan or any applicable award agreement to the contrary, all outstanding awards will become 100% vested (or in the case of restricted stock or restricted stock units, the restricted period will expire). In addition, in the event of a change in control, the Compensation Committee may in its discretion and upon at least 10 days’ advance notice to the affected persons, cancel any outstanding awards and pay to the holders thereof, in cash or stock, or any combination thereof, theno par value of such awards based upon the price per share, of common stock received or to be received by other shareholders of our Company in the event.

14

Fiscal 2023 Senior Management Equity Incentive Program

On November 7, 2022, the Compensation Committee approved the Charles & Colvard, Ltd. Fiscal 2023 Senior Management Equity Incentive Program (the “FY2023 Program”), with effectCorporation as of July 1, 2022.

The FY2023 Program provides an incentive opportunity for the Company’s executive officers, including our named executive officers (the “Eligible Employees”), through the grant of an award expressed in “Units” where each Unit consists of (i) a restricted stock award representing 65% of the Unit (the “Restricted Stock Component”) and (ii) a cash bonus award representing 35% of the Unit (the “Cash Component”).

Units granted under the FY2023 Program have both performance and service measures. Achievement of an Eligible Employee’s performance measures will be measured by the Committee as follows: (1) 65% of each Unit will be based on the achievement of a Company goal regarding revenue (the “Revenue Measure”); and (2) 35% of each Unit will be based on the achievement of a Company goal regarding EBITDA (the “EBITDA Measure” and together with the Revenue Measure, the “Company Measures”), all for the period from July 1, 2022 through June 30, 2023 (the “Performance Measurement Period”).

If the Company does not achieve 90% of the Revenue Measure, the Revenue Measure component of each Restricted Stock Component of each Unit will be forfeited and the Cash Component of each Unit related to such Revenue Measure will not be paid. Achievement of 90% or 100% of the Revenue Measure will result in payment of 50% or 75% of the portion of the Unit attributed to the Revenue Measure, respectively. Achievement of revenue rounding to 103% or 110% of the Revenue Measure will result in payment of 100% or 125% of the portion of the Unit attributed to the Revenue Measure, respectively, so long as the EBITDA Measure is achieved. If the Company does not achieve 100% of the EBITDA Measure, the EBITDA Measure component of each Restricted Stock Component of each Unit will be forfeited and the Cash Component of each Unit related to such EBITDA Measure will not be paid. In addition, an Eligible Employee must remain in continuous service until July 31, 2023 (the “Vesting Date”) for restrictions to fully lapse on the Restricted Stock Component and for the Cash Component to be paid.

Under the FY2023 Program, the Compensation Committee has granted the Chief Executive Officer 150,000 target Units and the Chief Financial Officer 75,000 target Units.

The foregoing description of the FY2023 Program does not purport to be complete and is qualified in its entirety by reference to the FY2023 Program, a copy of which is filed as Exhibit 10.1 to this Form 8-K and is incorporated herein by reference.

On October 13, 2023, the Compensation Committee reviewed corporate performance for the fiscal year ended June 30, 2023 and determined the achievement levels of the performance goals under the FY2023 Program. The Compensation Committee determined the performance goals were not achieved at target levels. Therefore, the Restricted Stock Component of each award was forfeited and the Cash Component of each award was not paid.

Pay Versus Performance

For the purposes of this Section, we have elected to take advantage of certain of the scaled disclosures available to the Company for smaller reporting companies. As required by Section 953(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and Item 402(v) of Regulation S-K, we are providing the following information about the relationship between executive compensation actually paid to certain individuals by the Company and certain financial performance of the Company.

15

Fiscal
Year
Summary
Compensation
Table Total for
PEO1
Compensation
Actually Paid to
PEO2
Average
Summary
Compensation
Table Total for
Non-PEO
NEOs3
Average
Compensation
Actually Paid to
Non-PEO
NEOs4
Value of Initial
Fixed $100
Investment
Based On
Company Total
Shareholder
Return5
Net (Loss)
Income6
(a)(b)(c)(d)(e)(f)(g)
2023$578,368$369,294$372,903$268,366$32$(19,580,794)
2022$1,181,214$628,211$609,227$400,959$40$2,373,915

1This column represents the amount of total compensation reported for Mr. O’Connell (our President and Chief Executive Officer) for each corresponding fiscal year in the “Total” column of the Summary Compensation Table. Please refer to the Fiscal 2023 Summary Compensation Table in this proxy statement.

2This column represents the amount of “compensation actually paid” to Mr. O’Connell, as computed in accordance with Item 402(v) of Regulation S-K. The amounts do not reflect the actual amount of compensation earned by or paid to Mr. O’Connell during the applicable fiscal year. In accordance with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to Mr. O’Connell’s total compensation for each fiscal year to determine the “compensation actually paid”:

Fiscal

Year

Reported 

Summary

Compensation

Table Total for

PEO(a)

Reported 

Summary

Compensation

Table Value of

PEO Equity

Awards (b)

Adjusted Value

of Equity 

Awards(c)

Compensation

Actually Paid to

PEO

2023$578,368$94,088$(114,986)$369,294
2022$1,181,214$531,205$(21,798)$628,211

(a)This column represents the amount of total compensation reported for Mr. O’Connell for each corresponding fiscal year in the “Total” column of the Fiscal 2023 Summary Compensation Table. Please refer to the Fiscal 2023 Summary Compensation Table in this proxy statement.

(b)This column represents the grant date fair value of equity awards reported in the “Stock Awards” column in the Fiscal 2023 Summary Compensation Table for the applicable fiscal year. Please refer to the Fiscal 2023 Summary Compensation Table in this proxy statement.

16

(c)This column represents an adjustment to the amounts in the “Stock Awards” column in the Fiscal 2023 Summary Compensation Table for the applicable fiscal year (a “Subject Year”). For a Subject Year, the adjusted amount replaces the “Stock Awards” column in the Fiscal 2023 Summary Compensation Table for Mr. O’Connell to arrive at “compensation actually paid” to Mr. O’Connell for that Subject Year. The adjusted amount is determined by adding (or subtracting, as applicable) the following for that Subject Year: (i) the fiscal year-end fair value of any equity awards granted in the Subject Year that are outstanding and unvested as of the end of the Subject Year; (ii) the amount of change as of the end of the Subject Year (from the end of the prior fiscal year) in the fair value of any awards granted in prior fiscal years that are outstanding and unvested as of the end of the Subject Year; (iii) for awards that are granted and vest in the Subject Year, the fair value as of the vesting date; (iv) for awards granted in prior fiscal years that vest in the Subject Year, the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in the fair value; (v) for awards granted in prior fiscal years that are determined to fail to meet the applicable vesting conditions during the Subject Year, a deduction for the amount equal to the fair value at the end of the prior fiscal year; and (vi) the dollar value of any dividends or other earnings paid on stock or option awards in the Subject Year prior to the vesting date that are not otherwise reflected in the fair value of such award or included in any other component of total compensation for the Subject Year. The amounts added or subtracted to determine the adjusted amount are as follows:

Fiscal Year

Fiscal

Year End

Fair Value

of Equity

Awards

Granted in

the Fiscal

Year

Fiscal Year

over Fiscal

Year Change

in Fair Value

of

Outstanding

and

Unvested

Equity

Awards at

Fiscal Year

End Granted

in Prior

Fiscal Years

Fair Value

as of

Vesting

Date of

Equity

Awards

Granted

and

Vested in

the Fiscal

Year

Change in

Fair Value

of Equity

Awards

Granted in

Prior

Fiscal

Years that

Vested in

the Fiscal

Year

Fair Value

at the End

of the Prior

Fiscal Year

of Equity

Awards

that Failed

to Meet

Vesting

Conditions

in the

Fiscal Year

Value of

Dividends or

other

Earnings Paid

on Stock or

Option

Awards not

Otherwise

Reflected in

Fair Value or

Total

Compensation

in the

Summary

Compensation

Table for the

Fiscal Year

Adjusted

Value of

Equity 

Awards

2023$0$0$0$(21,198)$(93,788)$0$(114,986)
2022$183,000$0$116,492$(164,840)$(156,450)$0$(21,798)

The fair value or change in fair value, as applicable, for performance-based awards was determined by reference to the closing price of our common stock on the applicable measurement date multiplied by the probability of achievement as of such date. For stock options, the fair value or change in fair value, as applicable, was determined by utilizing the Black-Scholes valuation mode. The model references the closing stock price, in addition to the stock option’s strike price, expected life, volatility, expected dividend yield, and risk-free rate as of the measurement date.

3This column represents the average of the amounts reported for the Company’s named executive officers as determined in accordance with Item 402(m)(2) as a group (excluding Mr. O’Connell) (NEOs), as reported in the “Total” column of the Summary Compensation Table in each applicable fiscal year. Please refer to the Summary Compensation Table in the Company’s proxy statement for the applicable fiscal year. The names of each of the NEOs (excluding Mr. O’Connell) included for purposes of calculating the average amounts in each applicable fiscal year are as follows: (i) for 2023, Mr. Pete; and (ii) for 2022, Mr. Pete.

4This column represents the average amount of “compensation actually paid” to the NEOs as a group (excluding Mr. O’Connell), as computed in accordance with Item 402(v) of Regulation S-K. The dollar amounts do not reflect the actual average amount of compensation earned by or paid to the NEOs as a group (excluding Mr. O’Connell) during the applicable fiscal year. In accordance with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to average total compensation for the NEOs as a group (excluding Mr. O’Connell) for each fiscal year to determine the compensation actually paid, using the same adjustment methodology described above in Note 2(c):

Fiscal

Year

Average 

Reported

Summary

Compensation

Table Total for

Non-PEO

NEOs(a)

Average 

Reported 

Summary

Compensation

Table Value of

Non-PEO NEO

Equity Awards(b)

Average Non-

PEO NEO

Adjusted Value

of Equity 

Awards (c) 

Average

Compensation

Actually Paid to

Non-PEO NEOs

2023$372,903$47,044$(57,493)$268,366
2022$609,227$241,501$33,233$400,959

(a)This column represents the average of the amounts reported for the Company’s NEOs as a group (excluding Mr. O’Connell) in the “Total” column of the Summary Compensation Table in each applicable fiscal year. Please refer to the Summary Compensation Table in the Company’s proxy statement for the applicable fiscal year.

(b)This column represents the average of the total amounts reported for the NEOs as a group (excluding Mr. O’Connell) in the “Stock Awards” column in the Fiscal 2023 Summary Compensation Table in each applicable fiscal year. Please refer to the Summary Compensation Table in the Company’s proxy statement for the applicable fiscal year.

17

(c)This column represents an adjustment to the average of the amounts reported for the NEOs as a group (excluding Mr. O’Connell) in the “Stock Awards” column in the Summary Compensation Table in the Company’s proxy statement for each applicable fiscal year determined using the same methodology described above in Note 2(c). For each fiscal year, the adjusted amount replaces the “Stock Awards” column in the Summary Compensation Table for each NEO (excluding Mr. O’Connell) to arrive at “compensation actually paid” to each NEO (excluding Mr. O’Connell) for that fiscal year, which is then averaged to determine the average “compensation actually paid” to the NEOs (excluding Mr. O’Connell) for that fiscal year. The amounts added or subtracted to determine the adjusted average amount are as follows:

Fiscal

Year

Average

Fiscal

Year End

Fair Value

of Equity

Awards

Granted in

the Fiscal

Year

Average

Fiscal Year

over Fiscal

Year Change

in Fair Value

of

Outstanding

and

Unvested

Equity

Awards at

FYE

Granted in

Prior Fiscal

Years

Average

Fair

Value as

of

Vesting

Date of

Equity

Awards

Granted

in the

Fiscal

Year and

Vested in

the Fiscal

Year

Average

Change

in Fair

Value of

Equity

Awards

Granted

in Prior

Fiscal

Years

that

Vested in

the Fiscal

Year

Average

Fair Value

at the End

of the Prior

Fiscal Year

of Equity

Awards

that Failed

to Meet

Vesting

Conditions

in the

Fiscal Year

Average

Value of

Dividends or

other

Earnings Paid

on Stock or

Option

Awards not

Otherwise

Reflected in

Fair Value or

Total

Compensation

in the

Summary

Compensation

Table for the

Fiscal Year

Adjusted

Average

Value of

Equity 

 Awards

 

2023$0$0$0$(10,600)$(46,893)$0$(57,493)
2022$91,500$0$34,096$(14,138)$(78,225)$0$33,233

5This column represents cumulative Company total shareholder return (TSR). TSR is calculated by dividing the sum of the cumulative amount of dividends for each measurement period (2022 and 2022-2023), assuming dividend reinvestment, and the difference between the Company’s share price at the end and the beginning of the measurement period by the Company’s share price at the beginning of the measurement period.

6This column represents the amount of net (loss) income reflected in the Company’s audited financial statements for the applicable fiscal year.

Description of the Information Presented in the Pay versus Performance Table

As described in greater detail in this Executive Compensation section, the Company’s executive compensation program reflects a pay-for-performance philosophy. While the Company utilizes several performance measures to align executive compensation with Company performance (as described in greater detail above), not all of those Company measures are presented in the Pay versus Performance table. Moreover, the Company generally seeks to incentivize long-term performance, and therefore does not specifically align the Company’s performance measures with compensation that is actually paid (as computed in accordance with Item 402(v) of Regulation S-K) for a particular fiscal year. Compensation actually paid is influenced by numerous factors, including but not limited to the timing of new grant issuances and outstanding grant vesting, share price volatility during the fiscal year, our short-term metrics, and many other factors. In accordance with Item 402(v) of Regulation S-K, the Company is providing the following descriptions of the relationships between information presented in the Pay versus Performance table.

The relationship between the Compensation Actually Paid to our PEO and the Compensation Actually Paid to the Other NEOs and the Company’s TSR.

The compensation actually paid to our PEO, as computed in accordance with the requirements of Item 402(v) of Regulation S-K, was $369,294 and $628,211 for 2023 and 2022, respectively. The average amount of compensation actually paid to the NEOs as a group (excluding Mr. O’Connell), as computed in accordance with Item 402(v) of Regulation S-K, was $268,366 and $400,959 for 2023 and 2022, respectively. The TSR of the Company, assuming an initial fixed $100 investment and computed in accordance with the requirements of Item 402(v) of Regulation S-K, was $32 and $40 for 2022-2023 and 2022, respectively. Please see Note 5 above for additional information related to the computation of Company TSR.

18

The relationship between the Compensation Actually Paid to our PEO and the Compensation Actually Paid to the Other NEOs and the Company’s Net Income.

The compensation actually paid to our PEO, as computed in accordance with the requirements of Item 402(v) of Regulation S-K, was $369,294 and $628,211 for 2023 and 2022, respectively. The average amount of compensation actually paid to the NEOs as a group (excluding Mr. O’Connell), as computed in accordance with Item 402(v) of Regulation S-K, was $268,366 and $400,959 for 2023 and 2022, respectively. The Company’s net (loss) income, as computed in accordance with Item 402(v) of Regulation S-K and reflected in the Company’s audited financial statements for the applicable fiscal year, was $(19,580,794) and $2,373,915 for 2023 and 2022, respectively.

19

FISCAL 2023 DIRECTOR COMPENSATION

The following table and narrative discussion summarize the compensation paid to our non-employee directors during fiscal 2023.

Name 

Fees Earned 

or Paid in Cash

($) 

  

Option

Awards

($)(1)

  

All Other

Compensation

($)

  
Total
($)
 
Neal I. Goldman $50,000  $34,221  $              -  $84,221 
Anne M. Butler  45,000   31,110   -   76,110 
Benedetta Casamento  50,000   31,110   -   81,110 
Ollin B. Sykes  40,000   31,110   -   71,110 

(1)The amounts shown in this column reflect the aggregate grant date fair values computed in accordance with FASB ASC Topic 718 of the option awards granted to each of our directors excluding the impact of estimated forfeitures. The assumptions made in determining these values are set forth in Note 12 to our consolidated financial statements included in our Annual Report on Form 10-K for the year ended June 30, 2023 filed with the SEC on October 12, 2023. As of June 30, 2023 the aggregate number of shares that were subject to option awards outstanding for each director was as follows: Mr. Goldman, 75,054 Ms. Butler, 319,672; Ms. Casamento, 112,873; and Mr. Sykes, 68,231.

Director Compensation Policy

On September 12, 2017, our Board of Directors adopted a revised director compensation policy, effective as of October 1, 2017, which provides that each designated non-management member of the Board of Directors will receive (i) an annual retainer of $30,000 to be paid in four quarterly installments in arrears, to be pro-rated as applicable; (ii) upon appointment to the Board of Directors to fill a vacancy, a stock option grant with a grant date valuebeen determined by the Board of Directors as appropriate considering the time remaining before re-election; and (iii)in its sole discretion at a stock option grant upon annual re-election as a director with a grant date valueratio of $50,000, except for the Chairperson, who will receive a stock option grant with a grant date value of $55,000, which vests contingent upon service on the Board of Directors until the Company’s next Annual Meeting of Shareholders following the grant date. Additionally, certain specific members of the Board of Directors will receive additional annual retainers, paid in four quarterly installments in arrears, pro-rated as applicable, in the following amounts: (i) the Chairperson will receive $40,000, in lieu of the $30,000 annual retainer paid to other members of the Board of Directors, (ii) the Chairperson of the Audit Committee will receive $15,000, (iii) the Chairperson of the Compensation Committee and Nominating and Governance Committee will receive $7,500 each, and (iv) Board committee members (excluding the committee chairperson) will receive $5,000. Directors will not receive a fee for each Board of Directors or committee meeting, whether or not such meeting is in person or telephonic. Members of the Board of Directors may only receive retainers for serving as a member (including chairperson) of two Board committees.

Stock Ownership Guidelines

To further align the interests of our non-management directors with the long-term interests of our shareholders and promote our commitment to sound corporate governance, our Board of Directors adopted stock ownership guidelines for the non-management directors on March 24, 2020. These guidelines provide that each non-management director achieve an ownership target of the numberone-for-[•] shares of our common stock having a value equal to or greater than 0.5 times such non-management director’s annual retainer for his or her service on the Board of Directors (but excluding any additional annual retainer amounts paid for service on a committee of the Board of Directors)Common Stock (the “Reverse Stock Split”). The non-management directors are expected to meet the target multiple within two years after first becoming subject to the guidelines and are expected to continuously own sufficientNo fractional shares to meet the guidelines once attained. All of our non-management directors met the target multiple within two years after first becoming subject to the guidelines and all of our non-management directors continue to own sufficient shares to meet the guidelines once attained.

20

EQUITY COMPENSATION PLAN INFORMATION

The following table sets forth information as of June 30, 2023 with respect to compensation plans (including any individual compensation arrangements) under which our equity securities are authorized for issuance.

Plan Category 

(a)

Number of securities

to be issued upon exercise of outstanding options, warrants and rights

  

(b)

Weighted-average exercise price of outstanding options, warrants, and rights

  

(c)

Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))

 
Equity compensation plans approved by security holders  1,817,665(1) $1.24   1,138,195(2)
             
Equity compensation plans not approved by security holders  -  $-   - 
             
Total  1,817,665  $1.24   1,138,195 

(1)

Includes 556,334 shares issuable upon exercise of outstanding stock options under the 2008 Plan, which expired (with respect to future grants) on May 26, 2018, and 1,261,331 shares issuable upon exercise of outstanding stock options under the 2018 Plan.
(2)

Consists of shares remaining for future issuance under the 2018 Plan, all of which are available for issuance in the form of restricted stock or other stock-based awards.

21

SECURITY OWNERSHIP OF MANAGEMENT AND CERTAIN BENEFICIAL OWNERS

The following table sets forth information with respect to the beneficial ownership of common stock as of October 17, 2023 by (i) each person known by us to own beneficially more than five percent of our Company’s outstanding shares of common stock; (ii) each director and director nominee of our Company; (iii) each named executive officer of our Company; and (iv) all current directors and executive officers as a group. Except as indicated in the footnotes to this table and pursuant to applicable community property laws, to our knowledge, each shareholder named in the table has sole voting and investment power with respect to the shares set forth opposite such shareholder’s name.

Name and Address of Beneficial Owner(1) Number of Shares Beneficially Owned(2)  Percent of Class 

Punch & Associates Investment Management, Inc.(3)
7701 France Avenue So., Suite 300
Edina, MN 55435

  2,076,511   6.8%

Carlos Daniel Valadez(4)
c/o Law Offices of Ryan Reiffert, PLLC
8118 Datapoint Dr.
San Antonio, TX 78229

  1,789,133   5.9 
Ollin B. Sykes(5)  2,696,217   8.8 
Neal I. Goldman(6)  1,312,816   4.3 
Don O’Connell(7)  951,114   3.1 
Anne M. Butler(8)  682,907   2.2 
Clint J. Pete(9)  379,328   1.2 
Benedetta Casamento(10)  343,902   1.1 
Directors and Executive Officers as a Group  (6 persons)(11)  6,366,284   20.9 

(1)Unless otherwise indicated, the address of each person is 170 Southport Drive, Morrisville, North Carolina 27560.
(2)

Based on 30,523,705 shares of common stock outstanding on October 17, 2023. The number and percentage of shares beneficially owned is determined in accordance with Rule 13d-3 of the Exchange Act and the information is not necessarily indicative of beneficial ownership for any other purpose. Under such rule, beneficial ownership includes any shares as to which the person has sole or shared voting power or investment power and also any shares that the person has the right to acquire within 60 days of October 17, 2023 through the exercise of any stock options or other rights. Any shares that a person has the right to acquire within 60 days are deemed to be outstanding for the purpose of computing the percentage ownership of such person but are not deemed outstanding for the purpose of computing the percentage ownership of any other person.

(3)

Based on a Schedule 13G/A filed on February 13, 2023 with the SEC, as updated by the Form 13F-HR filed by such investor with the SEC on August 14, 2023 indicating beneficial ownership as of June 30, 2023. Punch & Associates Investment Management, Inc., has voting and dispositive power over 2,076,511 shares.
(4)Based on a Schedule 13D/A filed on May 16, 2023 with the SEC. Mr. Valadez have sole voting power and dispositive power over 1,789,133 shares.
(5)Includes (i) 45,787 shares owned by Mr. Sykes’s spouse, over which Mr. Sykes may be deemed to have shared voting and investment power; (ii) 68,231 shares subject to options exercisable within 60 days of October 17, 2023; (iii) 1,175,000 shares held by the Sykes & Company Profit Sharing Plan and Trust, of which Mr. Sykes is the co-trustee; and (iv) 1,407,199 shares held in a margin account.
(6)Includes 75,054 shares subject to options exercisable within 60 days of October 17, 2023.

22

(7)Includes (i) 451,114 shares jointly owned with Mr. O’Connell’s spouse, over which Mr. O’Connell has shared voting and investment power; (ii) 500,000 shares subject to options exercisable within 60 days of October 17, 2023.

(8)

(9)

Includes (i) 319,672 shares subject to options exercisable within 60 days of October 17, 2023.

Includes (i) 120,000 shares subject to options exercisable within 60 days of October 17, 2023.

(10)

Includes (i) 112,873 shares subject to options exercisable within 60 days of October 17, 2023; and (ii) 20,600 shares owned by Ms. Casamento’s spouse, over which Ms. Casamento may be deemed to have shared voting and investment power.

(11)Includes (i) 1,195,830 shares subject to options exercisable within 60 days of October 17, 2023.

23

PROPOSAL 2

APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Audit Committee has appointed BDO USA, P.C., as our Company’s independent registered public accounting firm for the fiscal year ending June 30, 2024, subject to ratification by our shareholders. Although shareholder ratification of the appointment of BDO is not required by law, we desire to solicit such ratification as a matter of good corporate governance. If the appointment of BDO is not approved by a majority of the shares cast at the Annual Meeting, the Audit Committee may consider the appointment of another independent registered public accounting firm for fiscal 2024 but may determine to remain with BDO. BDO has acted as our independent registered public accounting firm since December 2010. Representatives of BDO are expected toshall be present at the Annual Meeting and will be given the opportunity to make a statement if they desire to do so and will also be available to respond to appropriate questions.

Principal Accountant Fee Information

For the fiscal years ended June 30, 2022 and 2023, fees billed for services provided by BDO are as follows:

  Amount of Fees 
Type of Service 2022  2023 
Audit Fees $217,000  $300,000 
Audit-Related Fees  -   - 
Tax Fees  2,000   - 
All Other Fees  -   - 
Totals $219,000  $300,000 

Audit Fees. This category includes fees billed for the fiscal periods shown for professional services for the audit of our annual financial statements included in our annual reports on Form 10-K, review of financial statements included in our quarterly reports on Form 10-Q, and services that are normally provided by the independent auditorissued in connection with statutory and regulatory filings or engagements for the relevant fiscal periods.

Audit-Related Fees. This category includes fees billed inReverse Stock Split. To the fiscal periods shown for assurance and related servicesextent that are reasonably relatedany shareholder shall be deemed after the Effective Date as a result of these Articles of Amendment to own a fractional share of Common Stock, such fractional share resulting from the Reverse Stock Split shall be rounded up to the performance of the audit or review of our financial statements and are not reported under the category “Audit Fees.” There were no “Audit-Related Fees” billed to us during fiscal 2022 or fiscal 2023.

Tax Fees. This category includes fees billed in the fiscal periods shown for professional services for tax compliance, tax advice, and tax planning. There were no “Tax Fees” billed to us during fiscal 2023.

All Other Fees. This category includes fees billed in the fiscal periods shown for products and services provided by the principal accountantnearest whole share. Each certificate that are not reported in any other category. There were no “All Other Fees” billed to us during fiscal 2022 or fiscal 2023.

The Board of Directors has adopted an Audit Committee Pre-Approval Policy. Pursuant to the Pre-Approval Policy, all new projects (and fees) relating to our independent registered public accounting firm either must be authorized in advance under the general pre-approval guidelines set forth in the Pre-Approval Policy or specifically approved in advance by the full Audit Committee. General pre-approval under the policy is provided for 12 months (unless the Audit Committee specifically provides for a different period), is limited to certain projects listed in the policy, and is subject to meeting a specific budget for each project, which budget is contained in the policy. Any project that falls within the scope of the general pre-approval guidelines but exceeds the budgetary limit up to $10,000 may be approved by the Chairperson of the Audit Committee or his or her designee, while all other projects must be specifically approved by the full Audit Committee. There were no new projects authorized during fiscal 2023.

THE BOARD OF DIRECTORS RECOMMENDS A VOTE “FOR” THE PROPOSAL TO RATIFY THE APPOINTMENT OF BDO USA, P.C. AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING JUNE 30, 2024.

24

PROPOSAL 3

ADVISORY (NONBINDING) APPROVAL OF EXECUTIVE COMPENSATION

Our executive compensation program is designed to attract and retain the executive talent essential to the achievement of our strategic and operational goals and the achievement of increased shareholder value. We believe that our compensation policies and procedures reward executive officers for both their performance and our Company’s performance, and we believe such compensation policies and procedures create interests for our executive officers that are strongly aligned with the long-term interests of our shareholders.

As required by Section 14A of the Exchange Act, we are providing our shareholders with an advisory (nonbinding) vote to approve the compensation of our executive officers. This proposal, commonly known as a “Say-on-Pay” proposal, is designed to give you as a shareholder the opportunity to endorse or not endorse our executive compensation program through the following resolution:

RESOLVED, that the shareholders approve, on an advisory basis, the compensation of our named executive officers, as disclosed in this proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission, including the compensation tables and the related narrative disclosure.”

When you cast your vote, we urge you to consider the description of our executive compensation program contained in this proxy statement, including in the compensation tables and narrative disclosure, as well as the following factors:

Compensation decisions for our Chief Executive Officer and other named executive officers are made by a committee of independent directors.

A substantial portion of our executive officers’ compensation is in the form of equity, which aligns our executive officers’ interests with those of our shareholders and incentivizes our executive officers to create shareholder value.

The Compensation Committee attempts to set challenging performance goals under our Company’s equity incentive programs, as demonstrated by the fact that our executive officers did not achieve their performance goals at the target level under the 2023 Program, resulting in the forfeiture of their underlying restricted stock awards and no payout of cash awards.

Because your vote is advisory, it will not be binding upon the Board of Directors, it will not overrule any decision by the Board of Directors, and it will not create or imply any additional fiduciary duties on the Board of Directors or any of its members. However, the Compensation Committee will take into account the outcome of the vote when considering future executive compensation arrangements.

THE BOARD OF DIRECTORS RECOMMENDS THAT THE SHAREHOLDERS VOTE “FOR” THE ADVISORY (NONBINDING) APPROVAL OF EXECUTIVE COMPENSATION.

25

OTHER MATTERS

The Board of Directors is not aware of any other matters to come before the Annual Meeting. However, if any other matters properly come before the Annual Meeting, it is the intention of the proxies appointed for the Annual Meeting to vote said proxy in accordance with their judgment in such matters.

SHAREHOLDER PROPOSALS

Under certain conditions, shareholders may request us to include a proposal for action at a forthcoming meeting of our shareholders in the proxy materials for such meeting. All shareholder proposals intended to be presented at our 2024 Annual Meeting of Shareholders must be received by us no later than June 29, 2024 for inclusion in the proxy statement and proxy card relating to such meeting.

In addition, if a shareholder desires to make a proposal from the floor during the meeting, even if such proposal is not to be included in our proxy statement, the Bylaws provide that the shareholder must deliver or mail timely written notice of the proposal to our Corporate Secretary. Notice will be considered timely if it is delivered or mailed to and received at our principal executive office between July 29, 2024 and August 28, 2024, which is not more than 90 calendar days and not fewer than 60 calendar daysimmediately prior to the one year anniversaryEffective Date represented shares of Common Stock (“Old Certificates”), shall, automatically and without the datenecessity of presenting the Notice of Annual Meeting of Shareholderssame for the immediately preceding annual meeting. In the eventexchange, thereafter represent that no annual meeting was held in the previous year or the date of the annual meeting has been advanced by more than 30 days or delayed by more than 60 days from the one year anniversary of the previous year’s annual meeting of shareholders, notice by a shareholder to be timely must be received no earlier than the 90th day prior to such annual meeting and not later than the 60th day prior to such annual meeting or the close of business on the 10th day following the day on which notice of the meeting was mailed or public disclosure of the date of the meeting was first made, whichever occurs first. To be properly brought before an annual meeting, a shareholder’s notice must set forth (in addition to any information required by applicable law) (i) a description of the business desired to be brought before the meeting and the reasons for conducting such business at the meeting; (ii) the name and address, as they appear on our Company’s books, of the shareholder proposing such business and the beneficial owner, if any, on whose behalf such proposal is made; (iii) the class and number of shares of our Company that are beneficially ownedCommon Stock into which the shares of Common Stock represented by the shareholder andOld Certificate shall have been combined, subject to the beneficial owner on whose behalf the proposal is made; (iv) any material interest, direct or indirect,elimination of the shareholder and such beneficial owner in such business; and (v) a representation that the shareholder is a holderfractional share interests as described above.”

3.
The amendment was approved by shareholder action, and such shareholder approval was obtained as required by Chapter 55 of the North Carolina General Statutes.
4.
These Articles of Amendment will become effective at , Eastern Time, on , 2024.
IN WITNESS WHEREOF, I have hereunto set my hand this day of record of shares of our Company entitled to vote at the meeting and intends to appear in person or by proxy at the meeting to present the proposal. If written notice is not timely given, the shareholder proposal will be considered untimely and we may exclude the proposal from consideration at the meeting. If the proposal is permitted to be considered at the meeting, the proxies appointed for the meeting will have discretionary authority to vote for or against the proposal even if the proposal was not discussed in the proxy statement.

ADDITIONAL INFORMATION

Copies of our Annual Report on Form 10-K for the year ended June 30, 2023, including financial statements and schedules, are available on our website at https://ir.charlesandcolvard.com/financials/annual-reports and will be provided upon written request, without charge, to any person whose proxy is being solicited. Written requests should be made to Corporate Secretary, Charles & Colvard, Ltd., 170 Southport Drive, Morrisville, North Carolina 27560.

By Order of the Board of Directors,

Neal I. Goldman

Chairman of the Board of Directors

October 27, 2023

2024.
CHARLES & COLVARD, LTD.
By:
Name:
Don O’Connell
Title:
President and Chief Executive Officer
26

A-1